Synaptic Protein Profiling in the Mammalian Brain by Heller, Elizabeth
Rockefeller University
Digital Commons @ RU
Student Theses and Dissertations
2009
Synaptic Protein Profiling in the Mammalian Brain
Elizabeth Heller
Follow this and additional works at: http://digitalcommons.rockefeller.edu/
student_theses_and_dissertations
Part of the Life Sciences Commons
This Thesis is brought to you for free and open access by Digital Commons @ RU. It has been accepted for inclusion in Student Theses and
Dissertations by an authorized administrator of Digital Commons @ RU. For more information, please contact mcsweej@mail.rockefeller.edu.
Recommended Citation
Heller, Elizabeth, "Synaptic Protein Profiling in the Mammalian Brain" (2009). Student Theses and Dissertations. Paper 116.
  
 
 
 
Synaptic Protein Profiling in the Mammalian Brain 
 
A Thesis Presented to the Faculty of 
The Rockefeller University 
in Partial Fulfillment of the Requirements for 
the degree of Doctor of Philosophy 
 
by 
Elizabeth Heller 
June 2009 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by Elizabeth Heller 2009 
 Synaptic Protein Profiling in the Mammalian Brain 
Elizabeth Heller, Ph.D. 
The Rockefeller University 2009 
 
The mammalian central nervous system (CNS) contains billions of neurons 
each receiving thousands of synaptic inputs.  Synapses are specified in part 
through the precise localization of synaptic proteins, yet it has not previously 
been possible to analyze the protein content of an individual class of 
synapses.  In order to achieve this, we have used the BAC (bacterial artificial 
chromosome) transgenic approach to target particular neurons for expression 
of a given neurotransmitter receptor fused to an affinity tag.  
Immunohistochemistry of fixed brain tissue confirmed the correct 
localization of each synaptic fusion protein to the appropriate cell type and 
morphological structure.  In order to isolate the synaptic proteins of interest, 
we developed a novel method, in which a classically purified crude 
synaptosome fraction was subject to size exclusion chromatography to 
enrich for synaptic protein complexes. The tagged synaptic protein 
complexes were then purified by immobilization with antibody-coated 
magnetic beads and the eluate analyzed by mass spectrometry.   
 This novel method was used to profile proteins at two classes of 
synapses.  First, we purified the parallel fiber to Purkinje cell synapse of the 
cerebellum.  We identified ~60 post-synaptic proteins, including those 
involved in phospholipid metabolism and signaling, which are major 
unrecognized components of this synapse type.  Second, we analyzed 
inhibitory synapses of layer V pyramidal cells of the cerebral cortex, thereby 
accomplishing the first successful in vivo purification of an inhibitory 
synaptic protein complex.  We identified ~12 proteins, many of which have 
been implicated in inhibitory synapse structure and function in vitro, such as 
the scaffolding protein, gephyrin.  The result of this work provides a novel 
approach for detailed investigations of the biochemical complexity of CNS 
synapse types.   
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CHAPTER I. INTRODUCTION 
Synaptic structure 
Information processing in the nervous system depends on the 
electrophysiological and pharmacological properties of neurons and 
neuronal elements.  The release of neuroactive substances at a specialized 
locus, the synapse, is the most common method by which neurons influence 
one another.  Neuronal activity at the synapse is classified by whether it 
increases (excitatory) or decreases (inhibitory) the membrane potential of the 
postsynaptic neuron.  Synapses can be broadly divided into two distinct 
classes: Type I (asymmetric) or Type II (symmetric), based on the relative 
density of material on the pre- and postsynaptic neuronal membranes (Figure 
1).  Although there are many exceptions, neurons making type I synapses 
typically have excitatory actions, while those making type II synapses have 
inhibitory actions [15].  All neurons receive both excitatory and inhibitory 
inputs, however, the postsynaptic location of these inputs is distinct.  
Broadly speaking, excitatory synapses are made on dendritic shafts, usually 
on dendritic spines, and not on somata or axons, while inhibitory synapses 
are generally found on proximal dendritic shafts, somta and axon initial 
segments [13, 17]. 
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Figure 1.  Gray’s Type I and Type II synapses. (A) Type I (asymmetric; 
excitatory).  The axons contain predominantly spherical vesicles and form 
synapses that are distinguished by a thickened, postsynaptic density. Scale  
bar = 0.22 µm. (B) Type II (symmetric; inhibitory) Axons contain clusters of 
vesicles that are predominantly flattened or elongated in their appearance. 
The pre-and postsynaptic membranes are more parallel than the surrounding 
non-synaptic membrane, and the synapse does not contain a prominent 
postsynaptic density [12].  Scale bar = 0.25 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
A large proportion of excitatory neurotransmission is due to pre-
synaptic release of the neurotransmitter glutamate, an excitatory amino acid.  
Glutamate receptor (GluR) channels function in fast excitatory synaptic 
transmission, synaptic plasticity, and higher brain functions such as learning 
and memory [18-20].  Based on pharmacological and electrophysiological 
properties, GluR receptors have been classified into three major subtypes: α-
amino-3-hydroxy-5-methyl-4-isozaxole propionic acid (AMPA), kainate, 
and N-methyl-D-aspartate (NMDA) receptors [15].  All these receptors are 
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components of tightly associated, multiprotein complexes.  Components of 
these complexes regulate the synaptic targeting or removal from synaptic 
sites, local expression, signal transduction, and clustering of receptors [22].    
Fast inhibitory neurotransmission is mediated by two different 
neurotransmitters in the nervous system: γ-aminobutyric acid (GABA) and 
glycine.  GABA is the most abundant inhibitory neurotransmitter of the 
nervous system.  Neurons that release this neurotransmitter form a diverse 
group that includes interneurons throughout the central nervous system 
(CNS).  Inhibitory neurotransmission plays a key role in controlling 
neuronal activity.  Accordingly, modulating the function of GABA receptors 
results in significant consequences for neuronal excitation [15].  In addition, 
these receptors are important for neural development and function, as 
demonstrated by gene deletion and mutation experiments [23].  GABA 
receptors are important therapeutic targets for a range of sedative, anxiolytic, 
and hypnotic agents, including a major class of anxiolytic molecules, the 
benzodiazepines.  They are also involved in a number of CNS diseases, 
including sleep disturbances, anxiety, premenstrual syndrome, alcoholism, 
muscle spasms, Alzheimer's disease, chronic pain, schizophrenia, bipolar 
affective disorders, and epilepsy [24].  Given the importance of GABA 
receptors in the central nervous system it is noteworthy that their interacting 
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synaptic proteins have been exceedingly difficult to purify and identify.  The 
molecular specialization at inhibitory synapses is an emerging field, and 
further work is likely to reveal novel therapeutics for treating a host of 
neurological and psychiatric conditions. 
 
Study of synaptic proteins 
Neurons interact with one another at the synapse, a specialized contact 
between the pre- and postsynaptic neuronal membranes.  The postsynaptic 
membrane of excitatory synapses contains a highly organized structure 
called the postsynaptic density (PSD), which is composed of glutamate 
receptors, associated signaling proteins, scaffolding proteins, and 
cytoskeletal elements [25].  AMPA receptor-interacting proteins are located 
in the PSD, and analysis of this specialized structure is crucial to the study of 
synaptic specificity. In many neurons in the mammalian brain, including 
pyramidal neurons of the cerebral cortex and hippocampus and Purkinje 
cells of the cerebellum, the PSD is located on membrane protrusions called 
dendritic spines.  The dimensions of the spine head are highly correlated 
with the size of the PSD and associated active zone, as well as synaptic 
strength [26].    Unlike excitatory synapses, inhibitory synapses lack a 
defined PSD and contacts are made on the dendritic shaft, the axon initial 
  5 
segment, or soma [15].  Biochemical analysis of excitatory synaptic 
elements benefits from the ease of enrichment of PSD through several steps 
of centrifugation [27], while inhibitory synaptic complexes are not easily 
enriched [28, 29].  Because of this difference in synaptic structure the study 
of synaptic proteins has been largely biased in favor of excitatory synapses.   
Classical PSD purification from the mammalian brain begins with 
homogenization followed by differential centrifugation and sucrose or 
Percoll gradient sedimentation to obtain synaptosomes [27, 30].  
Synaptosomes are formed from the phospholipid layer of the cell membrane 
and synaptic proteins and they also contain the presynaptic machinery 
necessary for the uptake, storage, and release of neurotransmitters [27, 30].  
Following synaptosome enrichment, the PSD is purified through extraction 
with nonionic detergents, such as Triton X-100 [27].  After purification, 
PSD proteins can be separated by SDS-PAGE (sodium dodecyl sulfate 
polyacrylamide gel electrophoresis) or two-dimensional gel electrophoresis, 
and major bands sequenced to identify abundant constituents such as 
postsynaptic density-95 (PSD-95), calcium/calmodulin-dependent protein 
kinase II (CaMKII), densin-180, synaptic GTPase-activating protein 
(SynGAP), and actin [31].     
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In recent years, large numbers of proteins in the PSD fraction or in 
immunoprecipitated GluR complexes have been detected by mass 
spectrometry (MS) methods, such as matrix-assisted laser 
desorption/ionization-time-of-flight (MALDI-TOF) MS and liquid 
chromatography (LC) coupled with tandem MS [32-38].  These experiments 
estimate the number of PSD proteins in the range of a few hundred to as 
many as one thousand.  However, this number includes many potential 
contaminants, including mitochondrial and glial proteins.  Furthermore, 
proteomic analysis of the PSD is likely to miss components that are in low 
abundance or only transiently associated with PSDs.  Finally, MS data do 
not measure copy number of isolated proteins, which results in a 
misrepresentation of the structural importance of a given postsynaptic 
element.  In order to address these issues, several experiments have aimed to 
accurately quantify the number of proteins in the PSD.  For example, 
quantitative electron microscopy (EM) and immuno-EM were used to 
determine the size and molecular weight of the PSD, as well as protein 
stoichiometry and distribution within the PSD [39, 40].  Based on the 
accumulation of evidence from these studies it was possible to estimate the 
likely number of different proteins in the PSD.  That is, if a PSD were 
composed solely of proteins of 100 kDa molecular mass, then there would 
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be 10,000 proteins, or 100 copies each of 100 different proteins, in an 
average PSD.  This estimation reflects an important conclusion, based on 
EM combined with quantitative immunoblotting, that the average PSD 
contained 300 copies of the scaffold protein PSD-95 [41].  Thus, it is likely 
that the available MS data have misrepresented the protein complexity of the 
PSD due to false positives, false negatives, and the lack of stoichiometric 
analysis.   
 Estimates of the number of proteins in the PSD that rely on bulk 
separation from whole brain, even in the case of specific receptor co-
immunoprecipitation, may falsely predict the protein complexity of the 
postsynaptic specialization.  Because the results reflect only the total number 
and identity of all postsynaptic proteins, they might inaccurately depict the 
structure of the PSD.  To improve the study of postsynaptic proteins it is 
crucial to enrich for only a subset of synapses, thus avoiding the additive 
effects of bulk separation.  Targeting PSD analysis to particular synapses in 
only certain cell types or regions of the brain will result in more accurate and 
meaningful data.  Moreover, a comprehensive approach, in which distinct 
PSDs are analyzed and then compared, will provide insight into the 
functional roles of such proteins, rather than simply brand them as 
generically postsynaptic.  Single synapse-type analysis of the postsynaptic 
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specialization is necessary in order to uncover the nature and mechanisms of 
synaptic specificity. 
 
Synaptic organization 
In structuring a study of synaptic specificity, it is important to consider what 
is already known about neuronal circuitry.   
 
Cerebral cortex 
Classification of cerebral cortical neurons originated two centuries ago.  
Based on their appearance in Golgi-stained preparations, neurons were 
characterized according to their size, shape, and dendritic branching pattern 
[42].  The principal neuronal types of the cerebral cortex are the excitatory 
pyramidal cells, which project to distant targets, and the inhibitory non-
pyramidal cells, which are the cortical interneurons.  Excitatory neurons 
release glutamate as their neurotransmitter and exhibit a spiny dendritic 
morphology, while inhibitory neurons are smooth and release the 
neurotransmitter GABA.  There are several types of spiny neurons including 
the pyramidal, star pyramidal, Betz, and spiny stellate cells [15].  
Immunohistochemical analysis revealed further details of the different types 
of interneurons, generating a list of relatively simple but reliable markers 
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Figure 2.  Canonical cortical circuitry.  Afferent fibers originating from 
the thalamus terminate predominantly in layer IV.  Here they 
glutamatergic spiny neurons, which are the main type of cortical input 
neuron, and GABAergic smooth neurons.  Layer IV spiny neurons relay 
excitation to pyramidal cells in layer II/III.  Within layer II/III, excitation 
is distributed laterally and vertically to other cortical layers, in particular 
to layer V.  Layer II/III pyramidal neurons also contact each other.  The 
output from the cortex is relayed from layer V to subcortical brain regions 
[13]. 
 
[43].  Projection neurons have been classified by the laminar position of 
their cell bodies, morphology, and electrophysiological characteristics [44], 
but there are relatively few neurochemical markers available for their 
identification.  As illustrated in Figure 2, the laminar structure of the cortex 
depends largely on the distribution of these various cell types. 
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The major excitatory afferents to the cerebral cortex are from the dorsal 
thalamus, which is arranged in nuclei that correspond to single or multiple 
sensory modalities.  The specific nuclei terminate mainly in layer IV and 
lower layers II/III, with a separate and less dense set of collaterals in upper 
layer VI.  The non-specific (intralaminar) nuclei terminate densely in layers 
V and VI.  Spiny stellate cells, the major cell type of layer IV, are the 
principal recipients of specific thalamocortical synapses.  These cells in turn 
project to other layer IV spiny stellate cells and to layer II/III pyramidal cells 
[45].  The same cells that receive thalamic input are often projection neurons 
as well; these are usually pyramidal cells.  The output from a pyramidal cell 
is specified by the layer in which the cell resides.  The general rule of thumb 
is that cortico-cortical connections arise mainly from the superficial cortical 
layers and that subcortical projections arise from the deep layers [17, 46, 
47].  Since the type of input to a cortical pyramidal neuron depends on its 
laminar location, synaptic molecules may be specific to the layer in which 
the postsynaptic cell is located.  This laminar specificity would facilitate the 
process by which incoming afferents form synapses only on cells of a 
particular layer.  A comparison of synaptic molecules based on the laminar 
location of the postsynaptic may provide insight into the molecular nature of 
such specificity. 
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 Laminar specificity is only one marker of neuronal identity.  Within a 
single cortical layer there exist distinct pyramidal cell populations.  Genes 
that regulate the production of cortical cell types have been identified [48-
50], but the molecular profile of a given neuronal cell type has remained 
largely unspecified.  Because of both molecular and genetic properties, the 
pyramidal neurons of layer V prove particularly amenable to classification.  
The large size of layer V cell bodies facilitates electrophysiological studies, 
single cell RT-PCR, and cell filling to examine somatodendritic morphology 
[51].  Pyramidal neurons of layer V of the adult rodent cortex fall into two 
major classes, which can be distinguished by their projection site, 
morphology, and physiological properties.  Type I cells project to the 
superior colliculus, spinal cord, or basal pons; they are characterized by 
thick tufted apical dendrites, and burst firing pattern.  Type II layer V 
pyramidal neurons project to the contralateral hemisphere or to the 
ipsilateral striatum.  Their apical dendrites are slender with fewer oblique 
branches that end without terminal tufts, usually in the upper part of layer 
II/III, and they do not exhibit burst firing [52].  Since these distinct 
projection neurons emerge sequentially within the very same layer, they 
constitute a unique model system to study cortical neuron specification [51].  
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Several techniques have been used to define protein markers of a 
given layer V pyramidal cell population.  In one study, a population of back-
labeled or GFP positive cell bodies from layer V transgenic lines was sorted 
and their gene expression profile was analyzed by microarray [53].  One 
marker of type I layer V pyramidal neurons, Otx1, is a transcription factor 
specifically expressed first in the ventricular zone and later in layer V and VI 
neurons [54].  Otx1 is required for the refinement of layer V connections to 
appropriate subcortical targets.  In Otx1 null mice, the normally transient 
pattern of exuberant connections is retained into adulthood [55].  
Comparison between several transcription factors reveals distinct subsets of 
pyramidal neurons within layer V, further subdividing Type I pyramidal 
neurons into distinct classes.  For example, retrograde tracing showed that 
Er81 was expressed in corticospinal and corticocortical neurons, while Otx1 
has been detected only in corticobulbar neurons [55].  The expression 
pattern of Otx1 exemplifies the use of genetic markers to define 
subpopulations of pyramidal neurons in cortex.  In designing a study of 
synaptic specificity, it is useful to first target a genetically defined class of 
neurons.  Analyzing only a particular synapse type within that class, which 
can be defined based on both synaptic morphology and the expression of 
particular synaptic markers, attains further specificity. 
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Cerebellum 
The cerebellum is a widely studied neuronal structure that has undergone 
major elaboration throughout evolution and is essential for motor 
coordination [15].  The basic organization of the cerebellum is that of an 
interaction site between two distinct neuronal elements: the cerebellar nuclei 
and cortex.  The cerebellar cortex receives afferents from the climbing and 
mossy fibers, while the main output is from the Purkinje cell (PC).  Purkinje 
cell axons make inhibitory synapses on the projecting cells of the cerebellar 
nuclei [56]. 
 The cerebellar cortex is divided into two distinct lamina: the 
molecular layer, which contains the Purkinje cells, and the granular layer.  
Climbing fiber afferents originate from a single brainstem nucleus, the 
inferior olive, and contact Purkinje cell dendritic spines in the molecular 
layer.  Although each Purkinje cell receives only one climbing fiber input, 
each inferior olive cell axon branches to form several climbing fibers.  The 
mossy fibers originate from a variety of CNS regions and synapse onto 
several granule cells, which increases the number of Purkinje cells 
stimulated by one mossy fiber axon.  The granule cell axon projects towards 
the molecular layer where it branches to form a parallel fiber that contacts 
the dendrites of Purkinje cells.  These fibers are found throughout the 
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Figure 3.  Diagram of the cerebellar circuitry. Climbing fibers, 
originating from the inferior olive, penetrate through the granular layer 
and make excitatory synapses onto Purkinje cell dendrites.  Granule cell 
axons project through the Purkinje cell layer to form the parallel fibers in 
the molecular layer.  Parallel fibers make excitatory contacts on the 
Purkinje cell dendrites.  The basket and stellate cells make inhibitory 
synapses onto Purkinje cell bodies.  Excitatory synapses are denoted by 
(+) and inhibitory synapses by (-). MF: Mossy fibers. DCN: Deep 
cerebellar nuclei. IO: Inferior Olive. CF: Climbing fiber. GC: Granule 
cell. PF: Parallel fiber. PC: Purkinje cell. GgC: Golgi cell. SC: Stellate 
cell. BC: Basket cell [14]. 
 
molecular layer and synapse onto the Purkinje cell dendrites as well as the 
dendrites of all other cells in the cerebellum, excluding granule cells [14, 
57].  
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The cerebellum comprises several other cell types that can be 
distinguished in part based on their laminar specificity.  The granular cell 
layer contains granule cells, which are contacted by mossy fiber axons, and 
Golgi cells, which form inhibitory synapses onto granule cells.  The Purkinje 
cell layer contains basket cells, which make inhibitory synapses onto the 
somata and initial segments of Purkinje cells and spiny cells, which make 
inhibitory synapses onto Purkinje cell dendrites [56]. 
The architecture of climbing fiber and parallel fiber inputs 
demonstrates the disynaptic input to the Purkinje cell.  Each Purkinje cell 
receives input from a single climbing fiber, whose afferents branch to 
“climb” along the entire dendritic tree, repeatedly contacting Purkinje cell 
dendritic spines.  Morphologically, the presence of a climbing fiber synapse 
seems to exclude nearby parallel fiber-Purkinje cell contacts, thus dividing 
the dendrites into a central area covered by the climbing fibers, and a 
peripheral spiny portion that is contacted by parallel fibers.  The distinct 
anatomy of these two excitatory inputs, as well as their molecular and 
functional differences (see below), make the Purkinje cell a useful model for 
the study of synaptic specificity.    
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Hippocampus 
The hippocampus is located inside the medial temporal lobe of the cerebral 
cortex, forming part of the telencephalon (forebrain).  It belongs to the 
limbic system and plays major roles in short term memory and spatial 
navigation [58].  As shown in part in Figure 4, the hippocampus and related 
areas comprise six distinct structures: entorhinal cortex (Ent), parasubiculum 
(PaS), presubiculum (PrS), subiculum proper (S), fields CA1-CA3 in 
Ammon’s horn (Amn), and dentate gyrus (DG) [21, 58].  Neurons from 
layer two of the entorhinal cortex send afferents to the hippocampus via the 
perforant path, which terminate in the dentate gyrus and CA3.  There is also 
a distinct pathway from layer 3 of the entorhinal cortex directly to CA1.  
Granule cells of the dentate gyrus send their axons, known as mossy fibers, 
to CA3.  CA3 axons branch to form the Schaffer collateral, which contacts 
neurons of CA1.  Pyramidal cells of CA1 send their axons to the subiculum 
and deep layers of the entorhinal cortex, thus completing the circuit.  The 
hilus (h), also known as CA4, is a transition area between CA3 and the 
dentate gyrus and contains several types of pyramidal cells, including 
scattered mossy cells and basket cells.  The mossy fibers make excitatory 
connections on the hilar basket cell neurons, which in turn form mainly 
inhibitory synapses on the granule cells.  It has been suggested that the 
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Figure 4. Connectivity in the hippocampus.  Perforant path (pp) is 
shown in brown.  Afferents from the entorhinal cortex (EC) innervate the 
outer molecular layer (oml) of the dentate gyrus (DG) and stratum 
lacunosum molecular (lm) layer of the cornu ammonis (CA).  Mossy fiber 
(mf) pathway is shown in blue.  These fibers connect DG with CA3.  
Schaffer collaterals (Sch) are shown in pink.  Abbreviations: a, alveus; p, 
stratum pyramidale; SUB, subiculum.  Circuitry diagram from review by 
T. Skutella and R. Nitsch [21].  
reciprocal connection between granule cells and basket cells forms an 
inhibitory feedback circuit [59, 60].  
 
 
 
 
 
 
 
 
 
 
 
  
 
In the hippocampus, as well as in the cerebellum and cerebral cortex, 
synaptic circuitry is further specified by the presence of particular 
neurotransmitter receptors.  In particular, the properties and distribution of 
AMPA and GABA receptors is instructive to the study of synaptic 
specificity in these various brain regions. 
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Excitatory synapses: AMPA receptors 
The glutamate receptor family comprises a diverse group of excitatory 
neurotransmitter receptors.  Twenty-eight recombinant glutamate receptor 
(GluR) cDNAs plus a considerable number of splice variants thereof have 
been cloned. These 28 GluR genes include 22 members of the ionotropic 
subfamily as well as six metabotropic receptors [16].  A major class of 
glutamate receptors is the ionotropic AMPA receptor, which contains a 
cation-specific ion channel.  The four AMPA receptor subunits, GluR1-
GluR4, contain a large extracellular N-terminal domain, four hydrophobic 
membrane segments, and an intracellular C-terminus, as shown 
schematically in Figure 5 [61].  AMPA receptors are either homomeric or 
heteromeric oligomers composed of multiple subunits.  Only two distinct 
subunits are usually found in a given receptor.  Differences in the functional 
properties of native AMPA receptors result from variable assembly of these 
subunits.  For example, all AMPA receptors are permeable to Na+ and K+, 
but homomeric receptors assembled from GluR2 subunits display little 
permeability to Ca++, while heteromeric receptors assembled from GluR2, 
GluR3 or GluR4 are highly permeable to Ca++.  In this way, the GluR2 
subunit is considered to regulate Ca++ permeability of the AMPA receptor 
[62].   
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Because differential subunit assembly results in distinct AMPA 
receptor functional properties it is of interest that each subunit is not 
uniformly expressed in all cortical laminae.  Studies by in situ hybridization 
as well as immunohistochemistry have elucidated the expression patterns of 
GluR1-GluR4 subunits in the rodent brain, as summarized in Table 1 [7-9].  
Figure 5. AMPAR subunit conformation.  The four AMPA receptor 
subunits, GluR1-GluR4, contain a large extracellular N-terminal 
domain, four hydrophobic membrane segments, and an intracellular C-
terminus.  Variation in C-terminal sequences of the various subunits 
results in binding to differential interacting proteins [16]. 
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Table 1: Distribution of AMPA receptor subunits.  
Immunohistochemical studies using antibodies against specific GluR 
subunits show that GluR1 and GluR3 expression is low in layers III and 
IV, while GluR4 expression is high in these layers.  GluR2 is distributed 
uniformly.  GluR1 immunoreactivity is low in layer IV, and GluR2/3/4c 
immunoreactivity is enriched highly in layers I, II, and III, low in layer 
IV, and enriched in deep layer V.  Differences exist in other non-cortical 
structures as well [7-9]. 
 
region/cell type GluR1 GluR2 GluR3 GluR4
cortex
layer I +++ ++
layer II/III + +++ + ++
layer IV + + +
layer V + +++ +
pyramidal n. + +++ ++
nonpyramidal n. +++
hippocampus
CA1 +++ +++ +++ +
CA3 +++ +++ +++ +
DG +++
striatum
spiny n. ++ +++ +++
aspiny n. +++
cerebellum
purkinje cells +++ +++
granule cells +++ ++
golgi cells
stellate/basket cells +++ ++
bergmann glia + ++
Differential receptor assembly will confer specific properties to the 
glutamatergic synapses in distinct areas of the brain. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Table 1. Distribution of AMPA receptor subunits. 
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GluRδ2 
GluRδ was found as a novel member of GluR channel family by molecular 
cloning [63].  GluRδ2, the second member of the GluRδ subfamily, is 
selectively expressed in Purkinje cells of the cerebellum [64] and within 
cerebellar Purkinje cells (PCs), GluRδ2 is localized postsynaptically at 
parallel fiber-Purkinje cell synapses, but not at climbing fiber-Purkinje cell 
synapses [65].  With respect to the amino acid sequence identity, the GluRδ 
subtype is positioned between the NMDA and non-NMDA subtypes [64].  
However, GluRδ2 has been referred to as an orphan receptor because it does 
not form functional glutamate-gated ion channels when expressed in 
transfected cells, either alone or with other GluRs, nor does it bind to 
glutamate analogs [64].  This receptor is predominantly expressed in 
Purkinje cells, and is crucial to cerebellar function.  Mice that lack the gene 
that encodes GluRδ2 [66] display ataxia and impaired long-term depression 
(LTD), a putative cellular model of cerebellar information storage [67].  
Despite their importance, the mechanisms by which GluRδ2 receptors 
participate in cerebellar function are not well understood. 
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AMPA receptor interacting proteins 
The class of AMPA receptors present at a given synapse type is one 
determinant of synaptic specificity.  Further refinement is achieved though 
the interactions of the receptor with postsynaptic molecules.  Many AMPA 
receptor binding proteins have been discovered using the yeast-two hybrid 
system, confocal microscopy and electrophysiology.  A description of a 
subset of such molecules follows below. 
PSD95 
The proteins found to interact with AMPA receptors can be roughly divided 
into two groups; those containing PDZ domains and those that interact 
through alternative sequences.  The PDZ domain is a protein–protein 
interaction motif of approximately 90 amino acids [31].  The scaffolding 
function of PDZ domain-containing proteins is exemplified by PSD95.  It 
contains three PDZ domains, an src-homology 3 (SH3) domain, and a 
guanylate kinase domain, which also acts as a protein interaction module.  
This multivalent structure allows PSD95 to arrange integral membrane 
proteins, including NMDA receptors, Shaker-type potassium channels, and 
the postsynaptic cell adhesion molecule, neuroligin.  PSD95 also likely 
functions to recruit functional mediators such as synGAP and neuronal nitric 
oxide synthetase and anchoring proteins such as CRIPT [68].  PSD95 
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contains a number of domains to bring a variety of proteins into close 
proximity to each other, providing a means to cluster, anchor, and regulate 
receptors.  
GRIP and APB 
GRIP (glutamate receptor interacting protein) was the first protein shown to 
interact with AMPA receptors by the yeast two-hybrid system.  Cloning of 
GRIP has demonstrated that it is a 130 kDa protein that contains seven PDZ 
domains, of which the fourth and fifth mediate binding to the C-termini of 
GluR2 and GluR3 [69, 70].  AMPA receptor binding protein (ABP) is 
related to GRIP in structure and shares 64–93% homology in the PDZ 
domains [71].  The functional implications of the interaction between GRIP 
and AMPA receptors remain unclear.  GRIP was proposed to have a role in 
the clustering of AMPA receptors, even though not all clusters of AMPA 
receptors contain GRIP immunoreactivity [69].  In heterologous expression 
systems ABP and GRIP alone do not aggregate with GluR2 despite 
interacting strongly [71].  The fact that GRIP has multiple PDZ domains 
suggests that it may function in bringing proteins together which are 
important in synaptic localization and clustering, especially at certain times 
in development or activity. 
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Stargazin 
The first transmembrane protein found to interact with AMPARs is 
stargazin, which is a member of a family of transmembrane AMPAR 
regulatory proteins (TARPs) that regulate the trafficking and physiology of 
AMPARs [72].  Stargazin is mutated in stargazer mice, which display 
absence epilepsy and lack functional AMPARs in cerebellar granule cells 
[73].  Stargazin plays two roles in trafficking AMPARs to synapses.  First, 
stargazin can associate with all four AMPAR subunits and traffic them to the 
plasma membrane.  Second, the extreme COOH terminus of stargazin can 
bind to PSD-95 and other PDZ proteins to mediate synaptic clustering of 
AMPARs [74].  The expression patterns for TARP family proteins in the 
central nervous system appear to cover all populations of neurons and glia 
that express AMPA receptors, suggesting a general role for this regulatory 
mechanism. 
Homer 
Homer acts as a postsynaptic adaptor protein that links multiple targets, 
including proteins involved in glutamate receptor signaling [75].  Alternative 
splicing results in two predominant forms of the Homer protein.  The short 
Homer forms lack the carboxy-terminal domain and are expressed in an 
activity-dependent manner [76].  The long forms are constitutively 
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expressed and consist of two major domains: the amino-terminal target-
binding domain, which includes an Enabled/vasodilator-stimulated 
phosphoprotein (Ena/VASP) homology 1 (EVH1) domain, and the carboxy-
terminal self-assembly domain containing a coiled-coil structure and leucine 
zipper motif.  These long Homer proteins form multimers that are thought to 
cluster other synaptic proteins, a process that may be required for synaptic 
function [77].  
Shank 
ProSAP/Shank molecules are early components of postsynaptic 
specializations present during synaptogenesis.  They are efficiently targeted 
to synaptic sites and contain several protein-protein interaction domains, 
namely ankyrin repeats, an SH3 and PDZ domain, proline-rich stretches, and 
a SAM (sterile alpha motif) domain [78].  The AMPA receptor GluR1 
subunit has recently been reported to interact directly with the PDZ domain 
of Shank [79] attaching the AMPAR complex to the other GluR complexes.  
GluRδ2 has been shown to interact with Shank protein by a yeast two-
hybrid screen and this interaction was confirmed with co-
immunoprecipitation experiments from synaptosomal plasma membrane 
(SPM) fractions collected from mouse cerebella [80]. 
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 The function of Shank protein in the cerebellum is likely related to the 
fact that it binds to Homer and GRIP [81].  It is known that Homer binds 
mGluR1α [82], whereas GRIP interacts with GluRδ2 [69]. Thus, Shank may 
organize mGluR1 and ionotropic AMPA receptors into a complex that is 
critical for cerebellar LTD induction.  Immunoprecipitation experiments 
with SPM fractions of cerebella showed that GluRδ2 indeed forms a protein 
complex with Homer and mGluR1α in vivo [80].  These results suggest that 
GluRδ2 regulates cerebellar synapse dynamics through the interaction with 
Shank proteins. 
 
Insertion of AMPA receptors into the synapse 
The type and number of AMPA receptor subunits present at a given synapse 
is variable, and depends on experience and age of the organism [83].  
AMPARs are characterized by their ability to move into and out of the 
postsynaptic membrane in a subunit-dependent fashion [84].  This AMPAR 
trafficking, which requires regulated endo- and exocytosis, depends not only 
upon receptor subunits and interacting proteins, but also upon the nature of 
synaptic stimulation or neuronal cell types [85].  It has been reported that 
receptors containing the GluR1-subunit are added to hippocampal synapses 
in an activity-dependant manner, a process that requires interactions between 
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GluR1 and group I PDZ domain proteins [86].  In contrast, GluR2/GluR3 
receptors replace existing synaptic receptors in a constitutive manner 
dependent on interactions by GluR2 with NSF and group II PDZ domain 
proteins [87].  Experiments in the mouse barrel cortex demonstrated this 
process in vivo.  Experience-dependent increases in synaptic strength at layer 
IV to II/III synapses were prevented by expression of a peptide that inhibits 
protein interactions with the intracellular C-terminal tail of GluR1 [88].  
These findings suggest crucial differences in the regulation of AMPAR 
subunit delivery to synapses. 
 Differences in domain organization of GluR1 and GluR2 subunits can 
partially account for differences in their regulation.  Two distinct C-terminal 
interaction domains on GluR2 have been characterized: an N-
ethylmaleimide-sensitive fusion factor (NSF)-binding site and an extreme C-
terminal PDZ-binding motif (ct-GluR2/3 PDZ).  The PDZ-binding motif has 
namely, GRIP, ABP, and protein interacting with C-kinase 1 (PICK1) [89, 
90].  GluR1, GluR3 and GluR4 do not interact with NSF, which has been 
shown to be involved in various membrane fusion events, such as exocytosis 
of synaptic vesicles.   
 The above examples illustrate differences in interacting proteins of the 
various AMPA receptor subunits; however, most studies to date have been 
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limited to a particular subunit in a particular cell type.  Furthermore, with the 
exception of the TARPs, most interacting proteins have been characterized 
with respect to trafficking of receptor subunits, rather than their channel or 
signaling functions.  While such studies suggest the existence of significant 
differences between the interacting proteins of individual subunits, a 
comprehensive approach to characterize such differences has not been 
carried out.  By isolating distinct populations of GluR-containing synapses 
from the intact brain and analyzing their protein content, it will be possible 
to elucidate such differences on a larger scale. 
 
Inhibitory synapses: GABAA receptors 
 
The GABAA receptor is a ligand-gated chloride ion channel, comprising five 
subunits selected from a pool of 19 distinct gene products [91].  Subunit 
rules for GABAA receptor assembly have emerged, with the largest group of 
GABAA receptors being made up of  α1γ2- and a β-subunit [10].  GABA 
neurotransmitter acts as an agonist, binding extracellulary between the α and 
β subunits and inducing a conformational change that increases permeability 
to chloride ions.  Each subunit consists of a short extracellular C-terminus, a 
large extracellular N-terminus, four transmembrane domains (TM1-TM4) 
and a large variable-sized cytoplasmic loop between TM3 and TM4, as 
  29 
Figure 6. GABAA receptor subunit composition.  Receptor subunits 
consist of four hydrophobic transmembrane domains (TM1-4), where 
TM2 is believed to line the pore of the channel.  The large 
extracellular N-terminus is the site for ligand binding as well as the 
site of action of various drugs.  Each receptor subunit also contains a 
large intracellular domain between TM3 and TM4, which is the site for 
various protein-protein interactions as well as the site for post-
translational modifications that modulate receptor activity [10, 11]. 
illustrated in Figure 6.  The intracellular loop contributes most of the 
cytoplasmic domain of the GABAA receptor and includes multiple protein-
protein interaction sites for trafficking and postsynaptic scaffold proteins and 
phosphorylation sites for diverse serine, threonine and tyrosine kinases [11].  
The amphiphilic TM2 domain provides the lining of the ion pore within the 
pentameric structure [10].   
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Many substances act as modulators of GABAA receptors.  Benzodiazepines 
are characterized by their anxiolytic, anticonvulsant, sedative, and amnesic 
effects.  They enhance the GABA-induced chloride current by allosteric 
modulation, increasing the frequency of chloride channel opening.  
Barbiturates, on the other hand, prolong the duration of chloride channel 
opening [92].  The particular subunit composition of the receptor influences 
its pharmacological properties.  For example, receptors composed of α1 or 
α2γ2β subunits respond to benzodiazepine and nonbenzodiazepine 
anxiolytics.  In contrast, receptors lacking γ subunits, or those γ-subunits 
combined with α4 or α6, are generally insensitive to the benzodiazepines 
and related drugs [93].   
The expression of GABAA receptor subtypes is spatially, regionally, 
and developmentally regulated, with individual subunits having distinct but 
overlapping expression patterns, as summarized in Table 2 [1-4].  In addition 
to differential subunit expression throughout brain regions, the GABAA 
receptor subunit composition varies between cell types and undergoes 
differential subcellular targeting.  The α4, 5, 6, and  δ-containing subunits 
are located extrasynaptically and are responsible for the tonic inhibitory 
current (persistent: long-term GABAA exposure at low concentrations), 
while all of the other GABAA receptor subunits—especially the γ2-subunit 
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Table 2. Immunohistochemical distribution of GABA receptor 
subunits throughout the mammalian brain [1-4]. 
 
containing GABAA receptors—are preferentially expressed on the synaptic 
site and are involved in phasic inhibition (transient: short-term GABA 
exposure at high concentrations) [94]. 
 
 
The significance of the structural diversity of GABAA receptors remains 
unknown.  One intriguing possibility is that the diversity in GABAA receptor 
subunits is important for mediating subcellular localization.  Differential 
subcellular targeting of GABAA receptors is best documented in 
hippocampal pyramidal neurons.  Here, receptors that contain α1 subunits 
seem to be equally distributed at all inhibitory synapses on the neuronal 
GABAAR 
Subunit 
Cerebral 
Cortex 
Cerebellum 
(PC layer) 
Cerebellum 
(Mol. Layer) 
Hippo-
campus 
(CA1) 
Hippo-
campus 
(CA3) 
α1 +++  +++ +++ +++ 
α2 ++  ++ ++ +++ 
α3 +    + 
α4 ++   ++ ++ 
α5 + + ++ +++ +++ 
α6   ++   
β1 ++ + + ++ +++ 
β2 +++  + +++ +++ 
β3 +++   +++ +++ 
γ1  +    
γ2 +++  + +++ +++ 
γ3 + ++ ++ + + 
δ +++   + + 
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somata, the proximal and distal dendrites, the spines, and the axon initial 
segments.  By contrast, receptors that contain α2 subunits are preferentially 
localized at axo-axonic synapses on the axon initial segments [95, 96].  The 
subunit-specific targeting of GABAA receptors has also been analyzed in 
cerebellar granule cells, which express a range of subunits, including α1, α6, 
β2, β3, γ2 and δ; these subunits can assemble as α1/β2/3γ2 or α6/β2/3δ 
combinations [4].  Receptors that contain δ subunits are specifically targeted 
to extrasynaptic domains [97, 98], whereas receptors that contain the γ2 
subunit are localized to synaptic sites on granule cells [99].  In addition to 
differential subcellular trafficking of the various GABA receptor subunits, 
receptor diversity likely confers specificity of GABA receptor interacting 
proteins. 
 
GABAA receptor interacting proteins 
While the structure and pharmacology of the GABAA receptors has been 
widely studied, analysis of the protein components of inhibitory synapses 
has been limited.  Studies to identify GABAA receptor interacting proteins 
have relied heavily on in vitro methods, such as the yeast two-hybrid system 
and heterologous cell expression systems.  A summary of some of the major 
interacting partners follows below. 
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GABARAP 
GABARAP is a GABAA receptor-associated and microtubule-associated 
protein originally found in a yeast two-hybrid system using the intracellular 
loop of γ2 as bait [100].  GABARAP is enriched predominantly in 
intracellular membranes including the Golgi apparatus and postsynaptic 
cisternae.  It is not found at significant levels within inhibitory synapses 
[101, 102].  Functionally, GABARAP acts as a linker protein between the 
microtubule protein tubulin and the intracellular loop of the γ2 subunit, 
which promotes the clustering of γ2-subunit containing GABAA receptors 
[100].  In addition, GABARAP has a basic N-terminus that can bind to 
tubulin and an ubiquitin-like C-terminal γ2 subunit-binding region.  
Additional binding partners of this multifunctional adapter molecule include 
gephyrin, GRIF-1, NSF, PRIP-1, and ULK1 [103, 104]. 
Gephyrin 
Gephyrin was originally found to anchor glycine receptors to the 
postsynaptic cytoskeleton [105].  Like GABARAP, gephyrin is a tubulin-
binding protein, and is involved in organizing postsynaptic GABAA 
receptors at inhibitory GABAergic synapses [28, 106].  Gephyrin is 
concentrated in the postsynaptic membrane at many inhibitory synapses and 
has been shown to colocalize with GABAA receptors [98], but a direct 
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interaction by co-immunopurification has not been demonstrated [107].  
GABARAP binds gephyrin and GABAA receptors directly, suggesting that 
GABARAP might function as the adaptor for the association of these two 
proteins.  Studies of the mechanisms for clustering of major GABAA 
receptor subclasses at GABA-dependent synapses have demonstrated that 
both the γ2 subunit of GABAA receptors and gephyrin are involved in 
receptor clustering, targeting and localization [108].  One study also 
revealed that synaptic GABAA receptors have lower levels of lateral 
mobility as compared to their extrasynaptic counterparts, and suggests a 
specific role for gephyrin in reducing the diffusion of GABAA receptors, 
facilitating their anchoring at inhibitory synapses [109].  Gephyrin is not 
required for clustering of all GABAR subunits, as demonstrated by a study 
of receptor localization in neurons of gephyrin deficient mice [110].  The 
punctate staining of GABAA receptor α1 and α5 subunits was unaltered in 
mutant mice, whereas the numbers of α2-, α3-, β2/3-, and γ2-subunit-
immunoreactive synaptic sites were significantly reduced.  This result 
demonstrates that additional mechanisms for GABAA receptor clustering 
may be revealed by studies of subunit-specific interacting proteins.  
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Profilin and mENA/VASP 
Neuronal gephyrin has also been shown to interact directly with key 
regulators of microfilament dynamics, such as profilins I and IIa, and with 
microfilament adaptors of the mammalian enabled (mENA)/vasodilator 
stimulated phosphoprotein (VASP) family, including neuronal mENA.  
Profilin and mENA/VASP coprecipitate with gephyrin from brain tissue and 
cultured cells.  Gephyrin, profilin, and Mena/VASP colocalize at synapses of 
rat spinal cord and cultivated neurons and in gephyrin clusters expressed in 
transfected cells [111].  Thus, mENA/VASP and profilin can contribute to 
the postulated linkage between receptors, gephyrin scaffolds, and the 
microfilament system and may regulate the microfilament-dependent 
receptor packing density and dynamics at inhibitory synapses. 
GRIP-1 
GRIP-1, which was first found in the glutamatergic system, also interacts 
with the γ2 subunit of GABAA receptors [69].  It exists in various splice 
forms, which localize differently in the intact brain.  It has been reported that 
GRIP1a/b localized to both GABAergic and glutamatergic synapses in 
cultured hippocampal neurons [69, 70], but not to GABAergic synapses in 
the intact brain [70].  GRIP1c is found to be present at excitatory synapses in 
both cultured neurons and intact brain as demonstrated by 
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immunofluorescence and electron microscopy.  Contrary to the other GRIP 
isoforms, it also localizes to GABAergic synapses, suggesting a possible 
role in GABAergic transmission.  GRIP1c does not co-immunoprecipitate 
with any GABAA receptors from brain extract, but rather with AMPA 
receptors [112].  GRIP1c might interact with GABAA receptors through 
GABARAP or other GABAA receptor associated proteins to participate in 
GABAA receptor trafficking and clustering.  Its exact role at inhibitory 
synapses remains unknown, although its ability to interact with GABARAP 
suggests that it may be involved in the synaptogenesis of inhibitory synapses 
or in the regulation of GABAA receptor function [104]. 
PRIP-1 
PRIP-1 (Phospholipase-C related catalytically inactive protein type-1) is an 
inositol 1,4,5-trisphosphate-binding protein similar in domain organization 
to phospholipase C-δ1 but lacking PLC activity.  PRIP-1 competitively 
inhibits the binding of the γ2 subunit of GABAA receptors to GABARAP, 
suggesting that this protein participates in GABAA receptor assembly and 
transport to the cell surface [113].  
PLIC-1 
Plic-1, is associated with the ubiquitination-degradation machinery 
(proteasome/ubiquitin-ligase), and contains a ubiquitin-like N-terminus that 
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is 33% identical to ubiquitin [114].  It also contains a carboxy-terminal 
ubiquitin-associated domain that interacts directly with the intracellular loop 
of the α- and β-subunit containing GABAA receptors.  Functionally, Plic-1 
facilitates GABAA receptor membrane insertion by increasing the half-life of 
intracellular receptor pools without modifying receptor endocytosis [114]. 
GRIF-1 
GRIF-1 (GABAA receptor interacting factor-1) is a member of a coiled-coil 
domain family of proteins thought to function as adaptors in the anterograde 
trafficking of organelles utilizing the kinesin-1 motor proteins to synapses.  
GRIF-1, has been shown to interact with the intracellular loop of the β2 
GABAA receptor subunit [115].  
GODZ 
The large intracellular loop of the γ2 subunit is rich in cysteine residues, 
which are absent from the equivalent domain of all the other subunits [24], 
suggesting that it might be a candidate for palmitoylation.  Recent work 
demonstrated that the γ2 subunit is palmitoylated on five cysteine residues in 
the large intracellular loop [116, 117].  Palmitoylation is required for 
controlling both GABAA receptor clustering at synaptic sites and for the cell 
surface stability of these proteins in neurons.  GODZ (Golgi-specific DHHC 
zinc finger protein) is a GABAA receptor interacting protein, which acts as a 
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neuron-specific thioacyltransferase that palmitoylates the intracellular loop 
of the γ2-subunit containing GABAA receptor [116]. 
AP2 
Dynamin-dependent endocytosis is important in the regulation of cell 
surface levels of a number of integral membrane proteins and involves their 
recruitment into clathrin-coated pits by adaptor proteins.  Internalization of 
GABAA receptors is mediated by clathrin-dependent endocytosis.  Recent 
studies have demonstrated that GABAA receptors associate with the adaptin 
complex protein, AP2, and colocalize with AP2 in cultured hippocampal 
neurons [118].  This interaction is mediated by the GABAA receptor γ2 
subunit, at a site specific for tyrosine phosphorylation [119], and the µ2 
subunit of AP2 [120].   
  
The above examples of GABAR- and AMPAR-interacting proteins 
demonstrate the importance of neurotransmitter receptor-interacting proteins 
in synaptic specificity and function.  In addition, there are many proteins 
present at the synapse that do not directly interact with receptors, such as the 
neuroligin family of cell adhesion molecules.  Further study of synaptic 
proteins will be crucial to broadening our understanding of the nervous 
system. 
  39 
Synaptic specificity 
The mechanism by which billions of neurons accurately form complex 
circuitries remains an area of intense study.  It is clear that developmental 
genetic programs play a key role in establishing synaptic circuitry.  Many 
molecules involved in axon guidance and synaptogenesis have been 
identified and their functions described [121, 122].  However, most of these 
molecules are found ubiquitously throughout the nervous system and are 
generic components of synapse formation, rather than markers of specific 
synaptic connections.   
One feature necessary for synaptic heterogeneity is cell-type specific 
expression of a protein, and targeting of that protein to all presynaptic or 
postsynaptic sites made by a cell.  On the presynaptic side, neurotransmitter 
synthetic enzymes and vesicular and plasma membrane transporters that 
determine the chemical nature of a synapse generally fall into this category.  
For example, the GABA synthetic enzyme glutamic acid decarboxylase 
(GAD65 and GAD67), the vesicular inhibitory amino acid transporter 
responsible for loading GABA into vesicles (VIAAT/VGAT), and the major 
plasma membrane transporter responsible for reuptake of GABA (GAT-1) 
are found at symmetric but not asymmetric synapses [123-126].  In situ 
hybridization studies indicate this is due primarily to expression by 
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GABAergic but not glutamatergic neurons [127, 128].  Thus, expression of a 
small number of genes or even a single gene can determine presynaptic 
transmitter phenotype. 
 In addition to genetic determinants, morphological constraints 
can direct specific synapse formation.  Certain subcellular domains can be 
permissive for specific synapse types and even selective for particular 
receptors.  For example, the axon initial segment of hippocampal pyramidal 
cells is permissive (or perhaps instructive) for formation of GABAergic but 
not glutamatergic postsynaptic sites [129].  Furthermore, GABAergic 
synapses on the axon initial segment have a higher density of the GABAA 
receptor α2 subunit than do GABAergic synapses on dendrites of the same 
cell, whereas the α1 subunit is more uniformly targeted to both 
somatodendritic and axon initial segment GABAergic synapses.  The results 
demonstrate that granule cells receiving GABAergic synapses at a restricted 
location on their distal dendrites exhibit a highly compartmentalized 
distribution of GABAA receptor in their plasma membrane [130].  The 
mechanism by which this differential subunit distribution is maintained 
could be uncovered by subunit-specific co-immunoprecipitation from 
hippocampal pyramidal neurons, followed by mass spectrometric analysis to 
identify unique interacting partners. 
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Another excellent example of specific localization of inhibitory inputs 
is found in the Purkinje cells of the cerebellum.  These neurons receive two 
sets of GABAergic inputs: the basket and stellate interneurons.  The stellate 
cells selectively innervate Purkinje cell dendrites, while the basket cells 
project to the axon initial segment, forming the so-called ‘pinceau synapses.’  
Using BAC transgenic mice in which basket cells were labeled throughout 
their development, pinceau synapse targeting was found to be achieved 
through multiple steps [131].  Basket axons first contact the Purkinje cell 
soma and subsequently migrate down towards the axon initial segment.  This 
migration was found to be dependant on a gradient of neurofascin, a member 
of the L1 subfamily of immunoglobulin proteins, which was found to 
emanate from the AIS towards the soma and dendrite.  The specificity of 
basket cell innervation demonstrates the subcellular targeting of inhibitory 
terminals and the role of guidance cues in development of synaptic 
specificity. 
Even within a single class of synapse (a single presynaptic cell type 
making synapses onto a single postsynaptic cell type), there exists a 
heterogeneity of features.  As in the case of GABAA receptor subunit 
distribution, differential GluR subunit distribution also contributes to 
synaptic specificity.  One example is the variability in postsynaptic AMPA 
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type glutamate receptor content in hippocampal pyramidal neurons.  
Quantitative electron microscopy studies of CA3 Schaeffer collateral 
synapses onto CA1 neurons found 19% of synapses strongly 
immunoreactive, 67% moderately immunoreactive, and 17% 
immunonegative for AMPA receptors [132].  Immunonegative synapses 
were exclusively the smaller synapses [133].  Because every Schaeffer 
collateral synapse onto CA1 pyramidal cell spines contains NMDA receptors 
[133, 134], a subset of these synapses express only NMDA receptors and 
could correspond to the anatomical substrate for the electrophysiologically 
defined 'silent synapses' [135].  These observations suggest that the targeting 
mechanisms and the regulation of cell surface expression of these two types 
of glutamate receptors follow different rules.  Indeed, recent studies indicate 
that, unlike NMDA receptors, AMPA receptors are highly mobile in a short 
time scale and that these dynamic properties are relevant for the observed 
heterogeneity in AMPA receptor synapse composition and could have an 
important part in mediating different forms of synaptic plasticity. 
Although there are limited examples of non-receptor molecules for 
synaptic specificity in the mammalian nervous system, one important family 
of cell adhesion molecules, the neuroligins (NLs) have been shown to 
possess some differential synaptic expression.  In vitro functional studies 
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indicate that an interaction between β-neurexin and neuroligins can trigger 
synapse initiation.  Axons from pontine explants form presynaptic vesicle 
clusters when they come into contact with non-neuronal cells that express 
neuroligin-1 or neuroligin-2 [136].  Neuroligin family members are 
differentially spliced, an observation that gave rise to the idea that 
differential localization and binding between them could serve to specify 
synapses.  For example, neuroligin-2 (NL-2) is a postsynaptic adhesion 
molecule that localizes at GABAergic synapses and triggers synapse 
formation by interacting with presynaptic neurexins [137, 138], while 
neuroligin-1 (NL-1) is targeted to glutamatergic synapses [136, 139].  This 
differential expression may play an important role in specifying distinct 
types of synapses and in determining a balance between neuronal excitation 
and inhibition [140].  The mechanisms responsible for the differential 
targeting of NL-1 to glutamatergic synapses and NL-2 to GABAergic 
synapses are unclear, although there is evidence that such specificity could 
arise from intracellular interactions with postsynaptic scaffolds [140].  
However, the binding partners of NL-2 at GABA synapses are not known. 
Further evidence for the role of synaptic adhesion molecules has 
proven elusive, even though Sperry’s 1963 Chemoaffinity Hypothesis 
proposed their function in specifying synapses [141].  Recent work 
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identified SYG-1 in a genetic screen for Caenorhabditis elegans mutants 
defective in synaptic positioning [142].  In SYG-1 mutants, the neurons that 
synapse on vulval muscles fail to cluster synaptic vesicles at their normal 
sites of synaptic contact; instead, vesicles are clustered at several ectopic 
sites. Vesicle clustering (and thus presumably synapse formation) at the 
correct location requires SYG-1-dependent contact with vulval epithelial 
guidepost cells, which may express specific receptors for SYG-1.  SYG-1 is 
likely to be the C. elegans orthologue of vertebrate NEPH1 [143], which are 
expressed in the CNS [144] and could play roles in synaptogenesis.   
The experiments described above exemplify recent approaches to the 
study of synaptic specificity, a crucial area in the field of neurobiology.  In 
order to elucidate the mechanism by which neurons form and maintain 
appropriate contacts it will be necessary to expand our understanding of 
synaptic proteins beyond neurotransmitter receptors and other ubiquitous 
components.  Furthermore, neurobiological disease often results from cell- 
or synapse-specific dysfunction [67, 145], necessitating an experimental 
approach that can target only the relevant structures.  In light of these issues, 
we have designed a novel approach to the study of the postsynaptic 
specialization in the adult mammalian CNS.   
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A novel approach to the study of synaptic specificity 
Previous studies into the complexity of the postsynaptic specialization and 
the methods of generating synaptic specificity are limited in scope.  A 
comprehensive approach to the nature of synaptic specificity in the 
mammalian brain has yet to be developed.  To address this issue, we have 
developed a novel approach that is schematically outlined in Figure 7.  
 
Cell-specific expression of a synaptic affinity tag 
In order to purify a single class of synapse, it was necessary to first identify 
a transmembrane protein with synapse specific expression.  As discussed 
above, this is likely to be a particular neurotransmitter receptor, as in the 
case of the cerebellar Purkinje cell molecule, GluRδ2, which is found only at 
the parallel fiber-Purkinje cell synapse.  The cDNA for a particular receptor 
subunit was N-terminally fused to cDNA for an affinity tag, Venus, a YFP 
variant.  Several groups have demonstrated that such a fusion protein, with 
GluR2 for example, is efficiently translated and inserted into the synaptic 
membrane as a functional receptor [83, 90].  The constructs were analyzed 
for expression and insertion into the membrane by transformation in 
heterologous cells followed by immunocytochemistry and immunoblotting. 
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Figure 7. Novel scheme for tagging and isolation of particular 
synapses.  Through a BAC transgenic approach, mice are generated that 
express a receptor-GFP fusion protein targeted to a single synapse type in 
a single cell type.  After biochemical purification of the postsynaptic 
specialization, the tagged synaptic complexes are affinity purified using 
an anti-GFP antibody.  Protein components are identified by mass 
spectrometry. 
 
 
 
 
To generate transgenic mice with cell-specific expression of a given 
Venus-receptor fusion protein, we relied on the bacterial artificial 
chromosome (BAC) transgenic approach [6, 146].  In this system, the fusion 
construct is inserted into the BAC downstream of the complete regulatory 
elements of a gene endogenously expressed in the neurons of interest.  The 
GENSAT [5] project has generated thousands of BAC lines that express 
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GFP alone.  An analysis of the expression patterns of such lines was used to 
select BACs that drive expression only in neuronal subpopulations of 
interest.  Figure 8 shows several of the BAC lines selected, and the particular 
cell types targeted by that line [5].   
We relied on SDS-PAGE and immunoblotting of whole brain extract 
as well as immunohistochemistry of fixed brain sections to verify expression 
of the receptor-Venus fusion protein in the transgenic animal.  In some cases 
immuno-electron microscopy was used to validate appropriate subcellular 
targeting of the receptor fusion protein to the correct synapse type.  Once 
expression of the fusion protein in a given transgenic line was confirmed, we 
went on to biochemically purify the tagged synaptic protein complexes. 
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Figure 8. Selection of BAC drivers for cell type specific expression.  
Each BAC transgenic line expresses GFP in a particular cell type 
(arrow).  By replacing the GFP coding region with that for a given 
protein of interest it is possible to target transgene expression to a 
particular neuronal cell population [5, 6]. 
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Purification of targeted postsynaptic protein complex 
In order to identify proteins at the synapse, rather than other subcellular 
compartments in which our fusion protein is localized, it was necessary to 
first enrich for the postsynaptic specialization.  We relied on both classical 
methods of synaptosome and PSD enrichment [27, 147] and a novel method 
in which a crude synaptosome fraction was detergent solubilized and 
separated by gel filtration.  An anti-GFP antibody immobilized on magnetic 
beads was used to affinity purify the tagged postsynaptic protein complex 
[148, 149].  The specificity of the isolated protein complex was verified by 
immunoblotting for known synaptic proteins (positive controls) and 
contaminants (negative controls).  Once the specificity of the approach was 
confirmed, we relied on mass spectrometric analysis to identify the specific 
postsynaptic protein components. 
 
Identification of synaptic proteins by mass spectrometry 
Mass spectrometric analysis was done in collaboration with members of the 
Laboratory of Mass Spectrometry and Gaseous Ion Chemistry at The 
Rockefeller University.  Synaptic protein samples were separated by SDS-
PAGE and stained with MS compatible staining methods, such as 
Coomassie blue or zinc staining.  Individual protein bands were excised, 
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reduced, alkylated and digested with trypsin.  The peptide mixtures were 
analyzed by various MS techniques, such as single stage (e.g. MALDI-
QqToF or MALDI-ToF), multiple stage (e.g. MALDI or ESI-IT) mass 
spectrometry, and on-line liquid chromatography tandem mass spectrometry 
(LC-MS/MS) to generate peptide sequence information [150, 151].  Such an 
approach has proved successful for analysis of the protein complex 
associated with the glutamate receptor, N-methyl-D-aspartate (NMDA) [32].   
 
Isolation of specific synapses for a comparative study 
The value of such a novel approach for discovering determinants of 
synaptic specificity lies in the fact that it enables the targeting of many 
different synapse types.  In order to decipher which proteins are functionally 
important, it is crucial to make useful comparisons between different 
synaptic populations.  
One such comparison is between excitatory and inhibitory synapses in 
the same cell type.  We expect there to be a considerable number of 
distinguishing proteins between these two types of synapses since they are 
functionally distinct, their receptors are genetically unrelated, they occupy 
distinct cytochemical locations on the postsynaptic neuron and they arise 
from distinct presynaptic cell types.  To discover such differences one could 
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examine the protein profiles of AMPAR-containing and GABAR-containing 
synapses in the same neurons (i.e. expressed under the same BAC control 
elements).  Any general determinants of inhibitory versus excitatory synapse 
specificity should be found in several types of either excitatory or inhibitory 
synapses, but not both.  Furthermore, such an experiment would result in the 
first successful biochemical purification of an inhibitory postsynaptic 
specialization, and would provide important insights into the nature and 
complexity of inhibitory synaptic structure. 
 Another interesting comparison is between excitatory synapses 
themselves.  As summarized above, studies on AMPA receptor subunit 
localization in the mammalian CNS have demonstrated striking differences 
in the expression profiles of individual subunits.  Inputs to the Purkinje cell 
(PC) of the cerebellum exemplify synaptic specificity, since all excitatory 
inputs to Purkinje cells contain the AMPA receptor GluR2 subunit, but only 
the parallel fiber to Purkinje cell (PF/PC) synapses contain the GluRδ2 
receptor.  Purification of the PF/PC synapse would uncover the molecules 
responsible for its unique structure and function.  Another example of 
excitatory synaptic specificity lies in the laminar organization of AMPARs 
in the cerebral cortex.  Pyramidal cells in the various cortical laminae 
receive distinct afferents and express unique but overlapping AMPAR 
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subunits.  Furthermore, pyramidal cells within a given layer can be 
subdivided into genetically and developmentally distinct populations.  A 
study to identify AMPAR interacting proteins specific to a given pyramidal 
cell population is possible due to the availability of BAC transgenic lines 
specific for pyramidal cell laminar expression (Figure 8).  Purification and 
identification of such molecules will expand our understanding of such cell 
populations, and prove useful in defining CNS cell and synapse types. 
 We have successfully generated multiple BAC transgenic mouse 
lines, each expressing a receptor-Venus fusion protein in a cell type of 
interest.  In addition, we have determined the technical limits of fusion 
protein expression in the adult mammalian CNS.  Using a novel approach to 
study the postsynaptic specialization we have successfully purified both 
excitatory and inhibitory synaptic protein complexes from distinct cell types.  
A comprehensive analysis at the results of this work follows. 
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CHAPTER II. MATERIALS AND METHODS 
Animals 
All experiments using animals were performed according to protocols 
approved by the Institutional Animal Care and Use Committee at the 
Rockefeller University.  All BAC transgenics were bred on the FVB 
background and littermates were used as wild-type controls. 
 
Antibodies 
The following antibodies were used at the indicated dilutions:  
rabbit anti-GFP, Abcam #ab6556 (1/5000 for immunoblotting; 1/500 for 
immuno-electron microscopy); rabbit anti-GluRδ2, Millipore #AB1514 
(1/2000); rabbit anti-GluR1, Abcam #ab31232 (1/1000); mouse anti-GluR2, 
Millipore #MAB397 (1/500); mouse anti-PSD95, Affinity Bioreagents 
#MA1-046 (1/2000); rabbit anti-PSD93 Millipore #AB5168 (1/100); mouse 
anti-NR2A, Millipore #MAB5216 (1/500); mouse anti-Gephyrin, BD 
transduction Laboratories #610584 (1/250); mouse anti-GABA(A) receptor 
β2/3, Upstate #05-474 (1/1000); rabbit anti- GABA(A) receptor α1, Upstate 
#06-868 (1/1000); rabbit anti- GABA(A) receptor α1, SantaCruz; rabbit 
anti- GABA(A) receptor α6, Millipore #AB5610 (1/2500); rabbit anti- 
GABA(A) receptor γ2, Millipore #AB6954 (1/1000); rabbit anti-Homer (H-
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342), Santa Cruz #sc-15321 (1/200); mouse anti-BiP/GRP78, BD 
transduction Laboratories #610978 (1/500); mouse anti-COX (cytochrome 
oxidase subunit I), Molecular Probes #A6403 (1/20000); rabbit anti-
RPTPmu, Abcam #ab23820; goat anti-BAIAP2, Abcam #ab15697; rabbit 
anti-delta2 Catenin, Abcam # ab11352; rabbit anti-mGluR1, Abcam 
#ab6439 (1/1000); guinea pig anti-VgluT1, Millipore (1/3000); guinea pig 
anti-VgluT2, Millipore (1/3000); mouse anti-GAD65/67, Stressgen 
bioreagents #MSA-225 (1/500); rabbit anti-GAD65/67, Millipore #AB1511 
(1/400); mouse anti-Gephyrin, BD trasnsduction Laboratories #610585 
(1/1000); rabbit anti-Gephyrin, Millipore #AB5725 (1/1000); goat anti-
Neuroligin-2, Santa Cruz #sc-14089 (1/50); mouse anti-GRIP (1/500), BD 
transduction laboratories #611318. 
 
Rabbit anti-Neph1 was a generous gift from Pr. Sumant Chugh. 
 
The polyclonal anti-Gm941 antiserum was custom-generated by injection 
into rabbits of peptide #1, LKEGDEEIKSDIYTLC, and peptide#2, 
PLKVERAPAPHGPC.  Bleeds were purified using protein G and then 
affinity-purified against peptide #2 (Green Mountain Antibodies, 
Burlington). 
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The polyclonal anti-MRCK gamma antibody was custom-generated by 
injection into rabbits of the following peptide: SERPRSLPPDPESESSPC. 
Bleeds were purified using protein G and then affinity-purified against the 
peptide (Green Mountain Antibodies, Burlington). 
 
The goat anti-GFP antiserum was generated by injection in a goat of the full-
length GFP (Green Mountain Antibodies) and was affinity-purified using a 
column made of Sepharose-4B resin coupled to full-length GFP. 
 
The monoclonal anti-EGFP antibody (clone 19F7) was generated by 
immunizing mice with purified GST-EGFP fusion protein (Monoclonal 
Antibody Core Facility at Memorial Sloan-Kettering Cancer Center, New 
York).  Several rounds of screening were performed to identify clones that 
functioned well in immunoprecipitation assays.  Initially, monoclonal 
supernatants were tested by ELISA using 96 well plates coated with EGFP 
purified from transiently transfected 293T cells.  Next, positive clones were 
screened in immunoprecipitation assays, again using the EGFP purified from 
transfected 293T cells.  Finally, we identified four positive clones which 
strongly immunoprecipitated EGFP from cerebellar lysates from a 
transgenic mouse line expressing EGFP under the Pcp2 BAC driver. 
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BAC modification and transgenic mice 
Pcp2-VGluRδ2 
The cDNA encoding GluRδ2 together with the 3’UTR was amplified from 
cerebellar RNA, and placed in frame with a preprotrypsin signal sequence 
and Venus in a building vector based on eGFP-C2 (Clontech, Mountain 
View).  The sequence encoding the tagged VGluRδ2 and the SV40 
polyadenylation signal from the building vector were subcloned into the 
PL53.SC-AB shuttle vector.  The Pcp2 containing BAC RP23-192G13 was 
then modified by homologous recombination using this shuttle vector and 
the two-step method [152].  Recombination boxes of 1kb were amplified 
from the BAC genomic DNA using the following primers: for box A, 
5’TTGGCGCGCCGGTTCCACCCTCATGTTG3’ AND 
5’AGCTTTGTTTAAACCCGATCGCCCTGCACGTGGGG3’; for box B, 
5’ATAAGAATGCGGCCGCCGGCTTTCTGGGTTCTGGC3’ and 
5’ATAAGAATGCGGCCGCGTTTAAGCCAGGTGTGGG3’.  These 
recombination boxes allow the replacement of the Pcp2 ATG by the cDNA 
construct.  Correct modification of the Pcp2 BAC was visualized by 
southern blot on BAC DNA digested by EcoRI, separated on 0.8% agarose 
gel and probed with P32dATP-labeled box A.  Pulsed-field gel 
electrophoresis was performed on BAC DNA digested by SpeI. 
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Otx1-VGABAA Rα1 and Otx1-VGluR1  
The cDNA encoding GABAA α1 or GluR1 together with the 3’UTR was 
amplified from cortical RNA, and placed in frame with a preprotrypsin 
signal sequence and Venus in a building vector based on eGFP-C2 
(Clontech, Mountain View, USA).  The sequence encoding the tagged 
VGABAA α1 or VGluR1 and the SV40 polyadenylation signal from the 
building vector were subcloned into the PL53.SC-AB shuttle vector.   
The Otx1 containing BAC RP23-106C14 was modified by homologous 
recombination using this shuttle vector and the two-step method [152].  
Recombination boxes of 1kb were amplified from the BAC genomic DNA 
using the following primers: for box A, 
5’AGCTTTGTTTAAACGCTAACAGCCGGGTGGAGGT3’ and 
5’TTGGCGCGCCGGCCTTCCAAAATCCCTAGA3’; for box B, 
5’AAGGAAAAAAGCGGCCGCCTGAGGGGACATGCGAGA3’ and 
5’CGACGCGTACCTCAAACAACCCCCATAC3’.  These recombination 
boxes allow the replacement of the Otx1 ATG by the cDNA construct.  
 
Additional BACs modified with VGluR1 
Several additional BACs were modified with Venus-GluR1.  The sequence 
encoding VGluR1 and the SV40 polyadenylation signal from the eGFP-C2 
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building vector were subcloned into the pLD53.SC2 shuttle vector.  The 
BAC was then modified by homologous recombination via a single 1kb box 
following previously published methods [146].  Using this modified shuttle 
vector it is not necessary to resolve the intervening sequences before 
injecting the modified BAC into oocytes for generation of transgenic mice. 
March4 (RP23-216L22)  
Box A 5’AGCTTTGTTTAAACCCCTCCAAGCAGCAAATA3’ 
5’TTGGCGCGCCGTCTTCTACCCCCACCCAAT3’ 
Glt25d2 (RP23-160M1) 
Box A  5’AGCTTTGTTTAAACGTTCCGTAGCCGGCGGGAGG3’ 
 5’TTGGCGCGCCTGTGCTGATCTTCCCACTCT3’ 
Ntsr1 RP23-314D14 
BoxA  5’GCATCGTCTCCAGTCCGAACTGTGGATGTGG3’ 
 5’ CAGGTTGAACTGCTGATCAACAGATC3’ 
Drd4 RP23-134L4 
BoxA  5’GATTCTGGCCCACGCCCGGCCAAC3’ 
 5’CAGGTTGAACTGCTGATCAACAGATC3’ 
Correct modification of the each BAC was visualized by southern blot on 
BAC DNA digested by EcoRI, separated on 0.8% agarose gel and probed 
with P32dATP-labeled box A.  
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A correctly modified BAC was purified by cesium chloride and DNA was 
then dialyzed in oocyte injection buffer for generation of transgenic mice. 
Integration of the BAC in the mouse genome was visualized by Southern 
blot using genomic DNA digested by EcoRI and box A as a probe. 
 
Preparation of synaptic protein complexes and affinity purification 
Pcp2-VGluRδ2 and Pcp2-EGFP 
Ten cerebella from adult mice were used for the preparation of a crude 
synaptosome fraction P2 (based on previously published protocols [147]). 
The solution used as a homogenization and resuspension buffer contained 
0.32M sucrose, 5mM HEPES, 0.1mM EDTA, pH=7.3 and a protease 
inhibitor cocktail (Sigma, Saint Louis).  P2 was then solubilized 30 minutes 
at 4°C using a final concentration of 0.5% Triton X-100.  The cleared 
solubilized fraction was separated by gravity flow on a gel-filtration column 
(Sephacryl S1000 Superfine, GE Healthcare) prepared using a solution 
containing 2mM CaCl2, 132mM NaCl, 3mM KCl, 2mM MgSO4, 1.2 mM 
NaH2PO4, 10mM HEPES and 0.5% Triton X-100, pH=7.4.  2 ml fractions 
were collected and aliquots were used for protein dosage using the BCA 
Protein assay kit (Pierce, Rockford).  Calibration of the gel-filtration column 
was performed using the gel filtration HMW calibration kit (GE Healthcare). 
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Pooled fractions from the column were used for affinity-purification 
of tagged PSDs.  Dynabeads M-270 epoxy beads (Dynal, Oslo) were 
conjugated using 15 mg of affinity-purified goat anti-GFP antibody per mg 
of beads [153].  6 mg of beads were used for affinity-purification of pooled 
synaptic fractions from 10 cerebella during one hour at 4°C.  Beads were 
then washed in 2mM CaCl2, 300mM NaCl, 3mM KCl, 2mM MgSO4, 1.2 
mM NaH2PO4, 10mM HEPES and 0.5% Triton X-100.  Purified complexes 
were eluted in 0.5N NH4OH, 0.5mM EDTA for 20 minutes, dried and 
resuspended in the desired volume of protein electrophoresis sample buffer.  
Biochemical preparations and affinity-purifications were performed in 
parallel for each genotype starting with 10 cerebella each.  For mass 
spectrometry analysis, samples from several successive experiments were 
pooled. 
 
 Otx1-VGABAARα1 and Otx1-GFP 
Five cortices from adult mice were used for the preparation of a crude 
synaptosome fraction P2 (based on previously published protocols [147]. 
The solution used as a homogenization and resuspension buffer contained 
0.32M sucrose, 5mM HEPES, 0.1mM EDTA, pH=7.3 and a protease 
inhibitor cocktail (Sigma, Saint Louis).  P2 was then solubilized 30 minutes 
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at 4°C using a final concentration of 0.1% Triton X-100.  The cleared 
solubilized fraction was separated by gravity flow on a gel-filtration column 
(Sephacryl S1000 Superfine, GE Healthcare) prepared using a solution 
containing 2mM CaCl2, 132mM NaCl, 3mM KCl, 2mM MgSO4, 1.2 mM 
NaH2PO4, 10mM HEPES and 0.1% Triton X-100, pH=7.4.  2 ml fractions 
were collected and aliquots were used for protein dosage using the BCA 
Protein assay kit (Pierce, Rockford).  Calibration of the gel-filtration column 
was performed using the gel filtration HMW calibration kit (GE Healthcare). 
Pooled fractions from the column were used for affinity-purification 
of tagged inhibitory synaptic protein complexes.  Dynabeads Protein G 
beads (Dynal, Oslo) were conjugated in 0.15M KCl for 2 hours at room 
temperature using 0.88 mg of mouse monoclonal anti-EGFP antibody per 
1mL of beads.  Following conjugation, the antibody was crosslinked to 
ProteinG with 20mM Dimethyl pimelimidate•2 HCl (Pierce, Rockford, IL) 
in 0.2 M triethanolamine, pH 8.0. The crosslinking reaction was stopped 
with 50mM Tris pH 8.0.  5mL of beads were used for affinity-purification of 
pooled synaptic fractions from 5 cortices during forty-five minutes at 4°C. 
Beads were then washed in 2mM CaCl2, 300mM NaCl, 3mM KCl, 2mM 
MgSO4, 1.2mM NaH2PO4, 10mM HEPES and 0.1% Triton X-100. Purified 
complexes were finally eluted in 1.0N NH4OH, 0.5mM EDTA for 20 
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minutes, dried and resuspended in the desired volume of protein 
electrophoresis sample buffer.  Biochemical preparations and affinity-
purifications were performed in parallel for each genotype starting with 5 
cortices each.  For mass spectrometry analysis, samples from several 
successive experiments were pooled. 
 
Otx1-VGluR1 and p338-VGluR1 
Between three and five cortices or ten hippocampi from adult mice were 
subject to biochemical purification of PSDs as described above for Pcp2-
VGluRδ2, the only difference was that the final concentration of Triton X-
100 was 1.0%. for cortex and 0.1% for hippocampus.  This percentage 
Triton X-100 was used for solubilization of the crude synaptosome fraction 
and in the gel filtration buffer.  Pooled fractions from the column were used 
for affinity purification as described above for Otx1-VGABAA α1.  
 
Protein extracts for expression analysis 
Total protein extracts from cerebellum, hippocampus or cerebral cortex were 
prepared by homogenizing the tissue and incubating for 30 minutes at 4°C in 
a buffer containing 50 mM Tris-Cl, 150mM NaCl, 0.1% SDS, 0.5% sodium 
deoxycholate and 1% NP-40 complemented with a protease inhibitor 
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cocktail.  The homogenate was then sonicated and centrifuged 30 minutes at 
maximum speed to provide the supernatant for western blot analysis. 
For immunoprecipitation experiments, the homogenate was incubated in 50 
mM Tris-Cl, pH=7.4, containing 1% Triton X-100 final for 30 minutes and 
then centrifuged at maximum speed.  The supernatant was affinity-purified 
using anti-GFP coated dynabeads for one hour at 4°C.  Beads were washed 
with 50 mM Tris-Cl, pH=7.4, containing 1% Triton X-100 and 
immunocomplexes eluted for western blot analysis. 
 
Immunoblotting 
Protein samples (dissolved in NuPAGE LDS sample buffer, Invitrogen, 
Carlsbad) were separated on 4-12% NuPAGE Bis-Tris gels (Invitrogen).  
Proteins were then transferred using the semi-dry method (SD transfer cell, 
Biorad, Hercules) on Immobilon-P PVDF membrane (Millipore, Bedford).  
Antibodies were diluted in 5% milk/PBS/0.2% Tween-20.  Secondary 
antibodies were conjugated to horseradish peroxidase (Pierce) and detection 
performed using a chemoluminescent substrate. 
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Immunofluorescence  
Mice were perfused transcardiacally using 4% paraformaldehyde in 
phosphate buffer saline pH=7.4 (PBS), then 10% sucrose in PBS.  Brains 
were incubated for 3 days in 30% sucrose in PBS.  25 mm-thick cerebellar 
or whole brain saggittal sections were cut using a freezing sliding 
microtome.  
For detection of VGluRδ2 or VGluR1, sections were incubated in 
0.3% H2O2 in PBS at 4°C, washed in PBS and preincubated in 4% normal 
donkey serum in PBS.  Incubation with the goat anti-GFP antibody (diluted 
1/25000 in 1% normal donkey serum/PBS/1% Triton X-100/0.1%fish 
gelatin) was performed overnight at 4°C.  Immunolabeling was detected 
using a biotinylated anti-goat secondary antibody (1/5000 in PBS/1% Triton 
X-100/0.1% fish gelatin) followed by amplification using streptavidin-HRP 
(1/500) and TSA-FITC (Perkin Elmer, Waltham, USA).  All washes were 
performed in PBS/1% Triton X-100. 
For detection of the other antigens by immunofluorescence, sections 
were incubated overnight with the corresponding antibodies and mouse anti-
calbindin (1/5000, Swant, Bellinzona) diluted in 1.0% normal donkey 
serum/PBS/0.2% Triton X-100.  Immunolabeling was detected using an 
Alexa-488 conjugated anti-rabbit or anti-goat and a Rhodamine-RedX 
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conjugated anti-mouse or Cy3 conjugated anti-guinea pig.  All washes were 
performed in PBS/0.2% Triton X-100.  Pictures were taken using a LSM 
510 laser scanning confocal microscope (Carl Zeiss, Thornwood, USA). 
 
Immuno-electron microscopy of Otx1-VGABAARα1 
Preparation of brain tissue for light and electron microscopy  
Transcardial perfusion was achieved by using a peristaltic pump to control 
the flow-rate of the perfusates to 10 ml/min.  The perfusates were the 
following: (1) 10 - 50 ml of saline containing heparin (1000 U/ml), over a 1-
min period; (2) 200 ml of 0.1 % glutaraldehyde, mixed with 4.0% 
paraformaldehyde in 0.1M phosphate buffer (pH 7.4).  During the 
subsequent hours, the brain was cut into 40 mm-thick sections using a 
vibratome.  On the 5th hour following the perfusion, the sections were 
immersed in PBS containing 1.0% sodium borohydride, so as to terminate 
residual cross-linking activities of glutaraldehyde.   
 
GAD65/67 and GFP Double Immunocytochemistry 
Double labeling using 3,3-diaminobenzidine HCl (DAB) and silver-
intensified colloidal gold (SIG) immunolabeling techniques were employed 
to mark the colocalization of Venus-GABAA α1 and GAD 65/67 [154].  
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Cortical sections were incubated for 30 min in PBS-azide containing 1% 
bovine serum albumin (BSA) (Sigma Chemicals, Saint Louis) to block any 
nonspecific immunolabeling.  These sections were then incubated on a 
shaker for 3 days at room temperature in PBS-BSA-azide containing 
primary antibodies, goat anti-GFP (1:500) to recognize Venus-GABAA α1, 
and rabbit anti-GAD65/67 (1:400).  This and all subsequent incubation steps 
were followed by 3 rinses in PBS (pH 7.4).  
 For immunolabeling with DAB, sections were incubated in biotinylated 
rabbit anti-goat IgG, recognizing the anti-GFP antibody, or in goat anti-
rabbit IgG, recognizing the anti-GAD antibody (Vector Laboratories, 
Burlingame), both at dilutions of 1:100 (15 mg/ml) for 1 hour at room 
temperature.  Sections were then incubated in the ABC solution (Elite Kit, 
Vector Laboratories, Burlingame) for 30 min and immersed in PBS (pH 7.4) 
containing 0.3% DAB with 0.03% hydrogen peroxide (H2O2) .  Reaction 
time was approximately 10 minutes for all sections. The peroxidase reaction 
was terminated by immersing sections in PBS.  This ICC reaction was 
followed by multiple postfixation steps to preserve ultrastructure: 1.0% 
glutaraldehyde with PBS (pH 7.4) for 10 min; 0.1% osmium tetroxide (in 
0.1 M PB) for 30 minutes; and 1.0% uranyl acetate in 70% ethanol, 
overnight.  
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 For Venus-GABAARα1 immunolabeling with SIG, sections were 
incubated for 16 hour in ultrasmall (0.8 nm) gold-conjugated rabbit anti-goat 
IgG (Electron Microscopy Sciences, Washington) at a dilution of 1:100 in 
PBS--BSA (pH 7.6).  Sections were then postfixed in 1.0% glutaraldehyde 
with PBS (pH 7.4) for 10 min to cross-link antibodies to antigenic sites prior 
to silver intensification.  To prepare sections for silver intensification, 
sections were rinsed for 1 min in 0.2 M citrate buffer (pH 7.4).  These 
sections were immersed into the silver intensification reagent (Silver 
IntensEM Kit, Amersham, Buckinghamshire) at room temperature for 12 
min.  The duration of the silver intensification step differed by no more than 
10 s among the samples.  Silver intensification was terminated by rinsing 
sections in citrate buffer.  These sections were stored in PBS overnight.  On 
the following day, sections were incubated in 0.1% osmium tetroxide (in 0.1 
M PB) for 30 minutes; and 1.0% uranyl acetate in 70% ethanol, overnight.  
  
Images used for were captured digitally using a CCD camera attached to a 
JEOL 1200XL electron microscope at a magnification of 40,000-60,000x 
and spanning and area of 29 mm2.  
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Mass spectrometry analysis 
Pcp2-VGluRδ2 and Pcp2-EGFP 
Following immunopurifications, the isolated proteins were resolved by 1-D 
SDS-PAGE and stained with Coomassie Blue (GelCode Blue, Pierce).  Each 
entire gel lane (from the 30 and 50 mice preparations) was cut into 1mm 
sections, and proteins were digested with 12.5ng/μL sequencing grade 
modified trypsin (Promega, WI, USA).  The resulting peptides were 
extracted on reverse phase resin (Poros 20 R2, PerSeptive Biosystems), 
eluted with 50% (v/v) methanol, 20% (v/v) acetonitrile and 0.1% (v/v) 
trifluoroacetic acid, and subjected to MALDI QqTOF MS and MALDI ion 
trap MS/MS analyses as described [155, 156].  
 
Otx1-VGABAA α1 and Otx1-EGFP 
Following immunopurifications, the isolated proteins were subject to 
analysis by LC-MS/MS based on previously published protocols [157].  
Immunopurified proteins were resolved by 1-dimensional SDS-PAGE and 
stained with E-ZincTM Reversible Stain Kit (Thermo Scientific, Rockford, 
IL).  Each gel lane was divided into two sub-samples.  One sub-sample 
contained all visible gel bands, and the other contained the gel regions 
between the bands.  Proteins in each sub-sample were subjected to in-gel 
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digestion by incubating with Trypsin (Roche, Indianapolis).  The resulting 
peptides were extracted onto POROS 20 beads (20 um C18 particles) 
(Applied Biosystem, Foster City).  For liquid chromatography-tandem mass 
spectrometry analysis, peptides were eluted and loaded onto a 360 µm o.d. x 
75 µm i.d. analytical column (6 cm long) packed with C18 5 µm sized resin 
(YMC Co., Kyoto) constructed with an integrated electrospray emitter tip 
(New Objective, Woburn).  Peptides were then eluted from the analytical 
column directly into a LTQ-Orbitrap mass spectrometer (Thermo Scientific, 
Waltham) using a HPLC solvent delivery system at a flow rate of 300nl/min.  
The acquired LC-MS/MS data were used to identify proteins present 
in each sub-sample by searching a mouse protein sequence database using 
the GPM database search program(http://prowl.rockefeller.edu 
/tandem/thegpm_tandem.html). Mass tolerances used in the database 
searching were 15 ppm and 0.4 Da, respectively, for measured masses of 
peptide ions and for fragmentation ions.  The cut-off score (the logarithm of 
E-value) of -4 is used for identified proteins.   Combining two lists of 
proteins from the two sub-samples of each IP sample, we generated a list of 
proteins present in the IP sample.  To obtain proteins uniquely present in the 
fusion protein IP sample, we subtracted proteins found in control IP sample 
from the list of proteins found in the fusion protein IP sample. 
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CHAPTER III. PROTEIN PROFILE OF THE PARALLEL FIBER-
PURKINJE CELL SYNAPSE  
Introduction 
The Purkinje cell (PC) is the major output neuron of the cerebellum, and its 
function is crucial for motor development and learning [56, 158].  The major 
excitatory afferents to PCs are from the granule cell (GC) axons, as they 
branch to form the parallel fibers (PFs), and from the climbing fibers (CFs), 
whose axons originate from the inferior olive.  Purkinje cells selectively 
express GluRδ2, a glutamate receptor subtype.  Although GluRδ2 protein is 
initially found at spines at CF/PC and PF/PC synapses, it localizes to PF/PC 
synapses after approximately P21 [65].  Because PFs form synapses on 
distal dendrites of Purkinje cells, a unique sorting mechanism must be 
necessary for GluRδ2 to bypass CF synapses, which are located at proximal 
dendrites.  The mechanism of such a sorting mechanism remains unknown, 
as it has not previously been possible to molecularly dissect the two synapse 
types. 
Dysfunction of the cerebellum typically manifests as motor 
discoordination, or ataxia, a common symptom of various neurological 
disorders in mice and humans.  Recent studies have also demonstrated the 
involvement of the cerebellum in non-motor functions and in 
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neuropsychiatric disorders such as dyslexia, autism, and attention deficit 
hyperactivity disorder [159-161].  The lack of specific pharmacological tools 
with which to manipulate GluRδ2 has hampered studies to determine its 
function.  However, studies of mutant mice, such as GluRδ2−/− and hotfoot, 
in which the receptor fails to traffic to the PC surface, have provided some 
clues to the function of GluRδ2 in Purkinje cells.  Ataxia is easily 
recognized as the phenotype of these mutations, but it is not accompanied by 
a macroscopic morphological anomaly in the cerebellum [66].  LTD of 
Purkinje cells from these mice is impaired in vitro, and they perform poorly 
on tasks that measure behavioral plasticity [161, 162].   
The factor(s) that activates GluRδ2 receptors, a ligand, a receptor 
subunit or associated messengers have yet to be found.  A better 
understanding of GluRδ2 function may provide key insights into normal and 
abnormal cerebellar functions and thus permit the development of novel 
approaches for therapy of particular neurological disorders.  To this end we 
targeted the parallel fiber-Purkinje cell (PF/PC) synapse for affinity 
purification and protein analysis by mass spectrometry using our novel 
approach.  
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Results 
Generation of mice with tagged parallel fiber – Purkinje cell synapses 
In order to specifically purify PF/PC synapses, we used molecular cloning to 
generate a synaptic tag consisting of GluRδ2 fused to an N-terminal affinity 
tag, Venus (a YFP variant).  This fusion protein was tested for proper 
expression and trafficking to cell surface in transfected HEK293 cells 
(Figure 9A).  Immunoblot analysis of protein extract obtained from 
transfected HEK293 cells shows that an anti-GluRδ2 antibody recognizes 
the fusion protein at the expected size, approximately 140 kDa, and that it is 
absent from cells transfected with Venus alone.  The GluRδ2 antibody 
recognizes the wild-type protein in cerebellar protein extract at a size smaller 
than the fusion protein by the expected 27 kDa.  Immunocytochemistry 
using an anti-GFP antibody shows surface expression of the Venus-GluRδ2 
(VGluRδ2) fusion protein in transfected HEK293 cells under non-
permeabilizing conditions, with the N-terminal Venus was localized 
extracellularly. 
 In order to express VGluRδ2 selectively in Purkinje cells of the 
cerebellum we relied on the BAC transgenic approach [6].  Homologous 
recombination was used to insert the transgene cDNA into the Pcp2 BAC 
[5], which contains the regulatory sequences for Purkinje  
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Figure 9. Construction of a fusion between Venus and GluRδ2 
(VGluRδ2). (A) Venus was fused on the N-terminal extracellular part of 
GluRδ2 (top left panel). A GluRδ2 positive band was detected in protein 
extracts from VGluRδ2 transfected HEK293 cells, but not in extracts 
from Venus-transfected cells (bottom left panel). The band was at the 
expected size (about 140 kDa), larger than the endogenous GluRδ2 
detected in cerebellar extracts. Immunofluorescence using an anti-GFP 
antibody detected the extracellular Venus in VGluRδ2 transfected cells in 
non-permeabilizing conditions (red, right panels), showing the proper 
topography of the tagged receptor. (B) The correct modification of the 
Pcp2 BAC with the VGluRδ2 construct was checked by Southern blot 
(left panel, probe shown in C, BAC DNA digested with EcoRI) and 
pulsed-field gel electrophoresis (right panel, BAC DNA digested with 
SpeI), before injection in mouse oocytes. (C) Schematic diagram of the 
BAC containing the Pcp2 gene, which is expressed specifically in 
Purkinje cells. The VGluRδ2 cDNA was placed at the level of the Pcp2 
ATG. The arrow indicates the regulatory region.  Scale bar = 0.5 Kb. 
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Figure 9.  Construction of a fusion between Venus and GluRδ2 
(VGluRδ2). 
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cell specific expression (Figure 9C).  Pulsed-field gel electrophoresis 
(PFGE) and Southern blotting (Figure 9B, left panel) were used to verify 
correct modification of the Pcp2 BAC.  The VGluRδ2 cDNA was placed at 
the level of the Pcp2 ATG, to disrupt expression of the endogenous BAC 
Pcp2 protein (Figure 9C). 
 We next generated transgenic mice containing the Pcp2-VGluRδ2 
construct, by surgical implantation of injected fertilized oocytes into a 
pseudopregnant female.  PCR screening and Southern blot analysis was used 
to determine both the presence and copy number of transgene insertion into 
the genome (Figure 10A).  The VGluRδ2 construct contains an additional 
EcoR1 restriction site, which enables the probe to distinguish the wild-type 
Pcp2 sequence from that contained within the BAC transgene.  Using this 
probe against whole genome DNA digested with EcoR1 reveals a second 
band present only in the transgenic mice that corresponds to the Pcp2-
VGluRδ2 transgene. 
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Figure 10. Tagging the parallel fiber/ Purkinje cell synapse in 
transgenic mice.  (A) Southern blot was used to identify transgenic mice 
having integrated the Pcp2 BAC containing VGluRδ2.  (B) VGluRδ2 
expression was detected using an anti-GFP antibody that recognizes 
Venus, on immunoblots from total protein extracts of transgenic (Tg) 
versus wild-type (Wt) cerebella. * indicates a non-specific band. (C) Both 
VGluRδ2 and GFP were affinity-purified using a goat anti-GFP antibody 
from 1.0% Triton X-100 cerebellar extracts from wild-type (Wt), 
Pcp2/VGluRδ2 (Vδ2) and Pcp2/EGFP control (GFP) mice, as shown by 
probing the immunoblots with an anti-GFP antibody (left). VGluRδ2 
specifically copurified the endogenous GluRδ2, as shown by probing the 
same blot with an anti-GluRδ2 antibody (right). (D) Immunofluorescence 
on cerebellar sections using an anti-GFP antibody shows the specific 
localization of VGluRδ2 in the molecular layer (ml) and somata of 
Purkinje cells (Pcl) of Pcp2/VGluRδ2 mice. Soluble GFP is detected in 
the molecular layer, dendrites, somata and axons of Purkinje cells in 
sections from Pcp2/EGFP mice. Abbreviations: ml, molecular layer; Pcl, 
purkinje cell layer; gcl, granule cell layer.  Scale bars: upper panels= 200 
 µm; lower panels= 50 µm. 
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Figure 10. Tagging the parallel fiber to Purkinje cell synapse in 
transgenic mice. 
 
To confirm expression of the VGluRδ2 transgene, we collected cerebellar 
protein extract from both wild-type and Pcp2-VGluRδ2 transgenic mice. 
SDS-PAGE followed by immunoblotting with anti-GFP antibody revealed 
the presence of the fusion protein at the expected size only in the transgenic 
mouse (Figure 10B).  The VGluRδ2 fusion protein was successfully affinity 
purified from cerebellar protein extract using a goat anti-GFP antibody 
(Figure 10C).  SDS-PAGE followed by immunoblotting with an anti-GFP 
antibody of the affinity-purified material from Pcp2/VGluRδ2 mice showed 
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the fusion protein present at the correct size.  This band was absent from 
material purified from wild-type mice.  In addition, we used a mouse 
expressing soluble GFP in Purkinje cells under the same Pcp2 BAC as a 
positive control for the affinity purification conditions.  The band 
corresponding to VGluRδ2 is absent, while the soluble GFP band is present 
at the expected size.  Immunoblotting of this same material with an anti-
GluRδ2 antibody reveals both the VGluRδ2 fusion protein and the wild-type 
GluRδ2 protein, demonstrating their successful oligomerization.  Neither 
GluRδ2 nor VGluRδ2 co-purified from the wild-type or Pcp2-GFP extract, 
demonstrating the specificity of the affinity purification method (Figure 
10C, right).  Immunohistochemistry on fixed cerebellar brain tissue 
confirmed correct expression and localization of VGluRδ2 in 
Pcp2/VGluRδ2 mice (Figure 10D).  Immunofluoresence using an anti-GFP 
antibody shows the expected localization of VGluRδ2 in the molecular layer 
and somata of Purkinje cells.  The expression pattern in Pcp2/VGluRδ2 
shows soluble GFP present in all layers of the cerebellum, including 
Purkinje cell dendrites and axons (Figure 10D, right).   
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Biochemical purification of tagged parallel fiber – Purkinje cell synapses 
In order to verify the presence of VGluRδ2 in the synaptic fraction from 
cerebellar extract, we used a previously published synaptosome enrichment 
method, which relies on centrifugation of homogenized cerebellar material 
through a discontinuous Percoll gradient [147].  The synaptosome fraction 
was enriched in endogenous synaptic proteins such as GluRδ2, 
GABAAR α1, and PSD95 (Figure 11, left panel), while BIP, an endoplasmic 
reticulum marker, and COX, a mitochondrial marker, were selectively 
absent. VGluRδ2 was detected in the synaptosome-enriched fraction and 
was distributed amongst the different fractions in the same manner as wild-
type GluRδ2.  Finally, electron microscopy of the synaptic fraction (3) 
showed enrichment for synaptosomes. 
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Figure 11. Synaptosome preparation from VGluRδ2 cerebella using 
the Percoll gradient method. Fractions were probed for excitatory 
synapse markers (GRID2, PSD95), the inhibitory synapse marker 
GABA(A)Ra1, the endoplasmic reticulum marker BIP and the 
mitochondrial marker COX. VGluRδ2 was detected using an anti-GFP 
antibody. The right panel shows an electron micrograph from fraction 3 
enriched in synaptosomes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Using the classical purification approach we successfully isolated the tagged 
parallel fiber to Purkinje cell synapse.  However, the material losses from 
this method were substantial.  In order to more efficiently enrich for the 
postsynaptic density (PSD) we developed a novel method based on 
solubilization of a crude synaptosome fraction followed by size exclusion 
chromatography to enrich for the PSD protein complex (Figure 12).   
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Figure 12. VGluRδ2 is detected in excitatory synaptic fractions 
using a new purification method. (A) We prepared a crude 
synaptosome P2 fraction that was solubilized in 0.5% Triton X-100. 
The extract was then separated on a Sephacryl S1000 gel filtration 
column. Calibration of the column indicated that protein complexes 
smaller than 669 kDa (arrow in B) were resolved after fraction 10.   
(B) Protein concentration was measured for every fraction collected. 
(C) 0.1% in volume of every fraction was assayed for the presence of 
excitatory synapse markers (GluRδ2, GLUR2, PSD95, NR2A), 
inhibitory synapse markers (GABA(A)Rβ, GABA(A)Rα1), the 
endoplasmic reticulum marker, BIP and the mitochondrial marker, 
COX.  VGluRδ2 was detected using an anti-GFP antibody.  The red 
rectangle outlines the “excitatory synaptic” fractions enriched for 
synaptic markers and pooled for subsequent affinity-purification of 
PF/PC PSDs. 
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Figure 12. VGluRδ2 is detected in excitatory synaptic fractions using a 
new purification method. 
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Homogenization of the cerebella from 10 mice was followed by differential 
centrifugation to enrich for synaptosomes (Figure 12A).  This fraction, P2, 
was solubilized with Triton X-100 at a final concentration of 0.5% to isolate 
the large, detergent-insoluble protein complexes, including the PSD.  To 
determine the relative enrichment of synaptic and non-synaptic proteins, 
each fraction was analyzed by SDS-PAGE and immunoblotting (Figure 
12C).  The solubilized crude synaptosome fraction (S3) is enriched for 
synaptic proteins such as neurotransmitter receptors (GluR2, GluRδ2, 
NR2A, GABAARβ2, GABAARα1), scaffolding proteins (PSD95), and 
presynaptic markers (synapsin I, synaptophysin).  In addition, VGluRδ2 was 
enriched in S3 like wild-type GluRδ2, suggesting correct trafficking of the 
fusion protein to the postsynaptic specialization.   
Next, the solubilized extract, S3, was fractionated using a Sephacryl 
S1000 gel filtration column (Figure 12C, right).  In this way we were able to 
separate large protein complexes (>669 kDa), which elute in the early 
fractions and likely correspond to the PSD, from those that elute later and 
are at a size consistent with intracellular protein complexes.  Protein 
concentration was measured for each fraction eluted from the column 
(Figure 12B).   Excitatory PSD proteins were selectively enriched in 
fractions 6-9 (Figure 12C, red triangle), as shown by the distribution of 
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GluRδ2, GluR2, NR2A and PSD95, as well as the fusion protein, VGluRδ2.  
On the other hand, inhibitory postsynaptic proteins (GABAARβ2, 
GABAARα1), presynaptic elements (synapsin I, synaptophysin), and 
endoplasmic reticulum (ER) marker (BIP) eluted later in the column and 
were largely excluded from the early, synaptic fractions.  In this way we 
successfully isolated a sample that is selectively enriched for excitatory 
PSDs from cerebellum.  
 This pool of PSDs was next subject to affinity purification using a 
goat anti-GFP antibody, to isolate the tagged parallel fiber to Purkinje cell 
synapses (Figure 13).  Co-immunopurified proteins were collected from the 
excitatory synaptic fractions of both Pcp2-VGlurδ2 mice and Pcp2-GFP 
mice, which served as a positive control for affinity purification conditions, 
and a negative control for co-immunopurification of synaptic proteins.  
Immunoblot analysis of the purified materials using an anti-GFP antibody 
indicated successful precipitation of the VGluRδ2 fusion protein or soluble 
GFP (Figure 13A).   
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Figure 13. Affinity-purification and protein profiling of the parallel 
fiber/Purkinje cell PSDs. (A) Synaptic fractions from Pcp2/VGluRδ2 
animals were affinity-purified using magnetic beads coated with anti-GFP 
antibody (VGluRδ2). In parallel, control purifications were performed on 
preparations from Pcp2/eGFP transgenic mice (GFP). 0.025% of the 
inputs and flow-throughs (FT) and 25% of the affinity-purified samples 
(IP) were assayed by Western blot using an anti-GFP antibody and 
showed immunoprecipitation of both VGluRδ2 and GFP, respectively. 
(B) The same blot was probed for different synaptic markers and the 
mitochondrial protein COX, showing specific co-purification of synaptic 
markers localized to the PF/PC synapse. (C) Electron microscopy electron 
dense structures reminiscent of PSDs on the surface of the magnetic beads 
used for affinity-purification of Pcp2/VGluRδ2 extracts. (D) Proteins 
from the affinity-purified VGluRδ2 PSDs were separated by SDS-PAGE 
and stained with Coomassie Blue before mass spectrometry analysis. (E) 
Mass spectrometry identified 65 different proteins in the complexes 
purified from Pcp2/VGluRδ2 mice. These proteins could be classified 
into 11 functional categories. The number of proteins from each category 
is indicated in parenthesis.  
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Figure 13. Affinity-purification and protein profiling of the parallel 
fiber/Purkinje cell PSDs 
 
Analysis by western blot demonstrated the co-immunopurification of several 
positive makers of the PF/PC synapse (GluRδ2, Homer, PSD93, GluR2/3, 
and PSD95) as well as the absence of inhibitory synaptic markers 
(GABAARα6, GABAARβ, gephyrin), presynaptic markers (synapsin I, 
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synaptophysin) and the mitochondrial marker (COX) (Figure 13B).  These 
results demonstrate the robust and specific isolation of the tagged parallel 
fiber to Purkinje cell synapse.  Furthermore, electron microscopy of the 
magnetic beads used for affinity purification showed the presence of 
electron dense structures resembling the PSD in both structure and size 
(Figure 13C).   
  
Mass spectrometry of the parallel fiber-Purkinje cell synapse 
Mass spectrometry (MS) was used to identify the proteins purified from both 
Pcp2-VGluRδ2 and Pcp2-GFP.  The material from several experiments was 
pooled (30 or 50 cerebella), separated by SDS-PAGE (Figure 13D) and 
analyzed by MALDI-TOF MS/MS.  A total of 65 proteins were identified: 
37 proteins were detected with high confidence (Table 3), and 28 were 
observed at lower levels and identified with less confidence (Table 4).  
Proteins known to be present at the PF/PC synapse and found by 
immunoblot analysis to co-purify with VGluRδ2 were confirmed by the MS 
results.  These include the wild-type GluRδ2, AMPAR subunit GluR2 and 
the scaffolding proteins PSD95, PSD93 and Homer3.  Additionally we were 
able to confirm the absence of presynaptic components and inhibitory 
neurotransmitter receptors and scaffolding molecules.  Also absent were 
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components of distinct excitatory PSDs, such as NMDA receptor subunits.  
Finally, we identified several additional scaffolding molecules previously 
shown to colocalize with GluRδ2, including Shank1 and Shank2, delphilin, 
and GluRδ2-interacting protein (Grid2ip).  
 The proteins we identified specifically at the PF/PC synapse could be 
grouped into eleven functional categories (Figure 13D; Tables 3 and 4).  
Several of the known markers for the PF/PC PSD were grouped as 
“scaffolds and adapters”, including several members of the Shank family 
and the PSD family. Other functional categories include proteins important 
for synapse formation and physiology, like regulators of small GTPases and 
protein kinases.  In addition to proteins of expected functional relevance, 
eight of the proteins identified in our study can regulate or be regulated by 
phospholipid metabolism (Itpr1, synaptojanin 1 and 2, phospholipase B, 
ABCA12, MRCKγ), or contain phospholipid-binding domains (Plekha7, 
annexin A6, MRCKγ).  Proteins in this group were previously unrecognized 
components of the PF/PC PSD and were thus grouped into a novel category, 
“phospholipid metabolism and signaling”. There is evidence to support the 
role of phospholipid regulation at this synapse, based on the known role of 
the metabotropic glutatmate receptor 1 (mGluR1) in regulating LTD through 
activation of phospholipase C [67].  Another important category of PSD 
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proteins contained receptors and ion channels, including glutamate receptor 
subunits and several G protein-coupled receptors (GABA-B and BAI 
receptors).  The BAI receptor, a G protein-coupled receptor, is likely to 
mediate cell adhesion [163].  Several other proteins identified at the PF/PC 
synapse in our study are involved in cell adhesion and interaction with the 
extracellular matrix: receptor protein tyrosine phosphatases [164], delta-
catenin-2 [165], and Neph1 [142].  The functional diversity of proteins 
present at the parallel fiber to Purkinje cell synapse may underlie the need 
for a multitude of molecules in specifying this synapse.   
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Table 3. List of proteins identified in the immunoisolates of Venus-
tagged GluRδ2. Results are shown of two replicate experiments from 
either 30 or 50 mice. The detection and confirmation of the proteins 
through MS and MS/MS analyses are indicated for both experiments. 
The number of peptides confirmed by MS/MS analysis is shown for 
each protein. The presence of these proteins in the control experiment, 
as judged by hypothesis-driven MS/MS analyses, is indicated. Where 
the presence or absence of the protein could not be judged 
conclusively, due either to depletion of sample or to inconclusive 
fragmentation, the entry is marked as not available (n/a). 
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Table 4. List of proteins identified in the immunoisolates of Venus-
tagged GluRδ2 with lower levels of confidence as judged by mass 
spectrometry. Results are shown from two replicate experiments from 
either 30 or 50 mice. The detection and confirmation of the proteins 
through MS and MS/MS analyses is indicated for both experiments. 
The number of peptides confirmed by MS/MS analyses is shown for 
each protein. Several proteins were not observed (n/o) at the MS 
analysis stage, but were identified from MS/MS analyses. The 
presence of these proteins in the control experiment, as judged by 
hypothesis-driven MS/MS analyses, is indicated. Where due to either 
depletion of sample or inconclusive fragmentation, the presence or 
absence of the protein could not be judged conclusively, the entry is 
marked as not available (n/a)  
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Confirmation of candidate proteins  
 To provide additional evidence for the synaptic localization of the 
novel components that we have identified, we performed 
immunofluorescence studies on cerebellar sections from wild-type mice.  
Localization in the molecular layer of the cerebellum, which contains the 
PF/PC synapses, was evident for MRCKγ, Gm941, BAIAP2, RPTPm, 
Neph1, and delta2-catenin (Figure 14). Delta2-catenin and Gm941 could 
also be detected in some cerebellar interneurons.  Examination of several in 
situ hybridization databases (www.stjudebgem.org; www.brain-map.org; 
www.genepaint.org) was used to confirm the expression pattern of candidate 
proteins.  Interpretable data were available for 42 candidates, and all but two 
were expressed in Purkinje cells, with a majority showing little detectable 
expression in the granule cell layer (data not shown).  These expression data 
provide additional confirmation that the majority of the proteins identified in 
our study are components of the PF/PC synapse.   
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Figure 14. Localization of novel components of PF/PC synapse.  
(A) Presence of selected candidates in PF/PC PSDs purified from 
Pcp2/VGluRδ2 cerebella.  0.025% of the inputs and flow-throughs (FT) 
and 25% of the affinity-purified samples (IP) obtained from Pcp2-GFP 
control (GFP) and Pcp2-VGluRδ2 (VGluRδ2) cerebella were assayed by 
western blot.  (B) Analysis of candidate synaptic proteins. 
Immunofluorescence labeling was performed using antibodies 
recognizing several candidate proteins identified by mass spectrometry 
(green) in conjunction with an anti-calbindin antibody specifically 
labeling Purkinje cells (red). Scale bars: 50 mm. 
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Summary 
 We have successfully targeted expression of a Venus-GluRδ2 fusion 
protein to the parallel fiber-Purkinje cell synapse of the cerebellum using the 
BAC transgenic approach.  The fusion protein displays correct topography in 
heterologous cells and is present in classically purified synaptic fractions 
from mouse cerebellum.  Purification of the tagged PF/PC synapses was 
achieved with a novel biochemical method that relies on solubilization of a 
crude synaptosome fraction followed by gel filtration to enrich for PSDs.  
The tagged PF/PC synaptic complex was affinity purified from this PSD 
fraction and analyzed by mass spectrometry.  Using this approach we 
identified approximately 65 proteins, including a novel group of 
“phospholipid metabolism and signaling” proteins, which are previously 
unrecognized components of this synapse.   
Among the proteins identified were several that represent novel 
members of this synapse, such as GPM741, RPTPm and BAIAP2.  Using 
immunohistochemistry and immunoblotting we confirmed the Purkinje cell 
specificity of several candidate proteins identified by mass spectrometry. 
This work represents the first successful purification of an individual 
synapse type, and demonstrates the strength of such a strategy in uncovering 
novel functional components of a particular synapse type. 
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CHAPTER IV. EXPRESSION OF AN AMPA RECEPTOR FUSION 
PROTEIN IN CORTICAL PYRAMIDAL NEURONS 
Introduction 
A study of synaptic specificity, and the potential for uncovering a “synaptic 
code,” is facilitated by the ability to tag and purify multiple synapse types 
for a comparative study.  The GENSAT project has facilitated such an 
approach, in that we can quickly generate multiple lines of transgenic mice 
each expressing a synaptic tag in a distinct cell population.  We have taken 
advantage of this in designing a study of AMPA receptor subunit GluR1 
containing excitatory synapse types across distinct laminae of the cerebral 
cortex.   
 The distribution of AMPA receptor subunits varies across cortical 
laminae, but the GluR1 subunit is present abundantly in all pyramidal 
neurons.  A comparison of excitatory synaptic protein complexes would 
validate the known subunit expression patters as well as expand the protein 
profile of these synapses to include additional molecules important for 
laminar specificity of excitatory inputs.  In addition, it is possible to discover 
tissue specific markers of excitatory synapses by comparison of GluR1-
containing cortical synapses to the GluRδ2-containing Purkinje cell 
synapses we have previously analyzed. 
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Results 
Cloning and expression of a Venus-GluR1 fusion protein 
In order to tag and purify excitatory synapses, we designed a GluR1 fusion 
protein with an affinity tag, Venus, located extracellularly at the N-terminus 
(Figure 15A).  This fusion protein has proved useful in studying AMPA 
receptor trafficking and protein interactions in a multitude of experiments 
both in cultured neurons and in vivo [84, 86, 88].  We confirmed expression 
and membrane trafficking of the Venus-GluR1 fusion protein (VGluR1) in 
HEK293 cells.  Transfected cells were processed for immunochemistry 
under non-permeabilizing conditions using an anti-GFP antibody, which 
showed Venus localized extracellularly (data not shown).   
 We next generated transgenic mice that express the Venus-GluR1 
fusion protein under Otx1 gene regulatory elements, using the Otx1 BAC 
(Figure 15D).  This BAC has been shown to drive expression in a 
subpopulations of cortical layer V pyramidal neurons.  Correct modification 
of the BAC was confirmed by Southern blotting (Figure 15B) and 
subsequently injected into oocytes for implantation into pseudopregnant 
females.  Transgenic mice were identified by Southern blotting of genomic 
DNA (Figure 15B). 
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Figure 15.  Expression of a Venus-GluR1 fusion protein in mouse 
cortex.  (A) Schematic of AMPA receptor subunit GluR1 N-terminally 
fused to an affinity tag, Venus.  The tag is present extracellularly.   
(B) Southern blotting confirmed correct modification of an Otx1 BAC 
with the Venus-GluR1 cDNA.  Insertion of the transgene into the wild-
type BAC (Wt) introduced an additional EcoR1 restriction site, resulting 
in hybridization of the probe (red, in D) on a restriction band of smaller 
size (Mod.).  Genomic DNA from a wild-type (Wt) and transgenic (Tg) 
mouse was analyzed by Southern blotting.  The transgenic mouse shows 
two bands, corresponding to the BAC transgene and the endogenous 
Otx1 sequence.  (C) Whole protein extract was collected from transgenic 
(Tg) and wild-type (Wt) mouse cortex, separated by SDS page and 
immunoblotted with an anti-GFP antibody.  Extract from the transgenic 
mouse shows a band corresponding in size to VGluR1.  The lower non-
specific band is present at equivalent levels in tissue from both animals.  
(D).  Schematic of the Otx1 BAC transgene modified with Venus-GluR1.  
The VGluR1 was inserted such that it disrupted the Otx1 ATG.  
Approximately 75 Kb of upstream regulatory sequences is present in the 
BAC.  Scale bar = 2 Kb. 
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We next tested the transgenic mice for expression of VGluR1 by 
immunoblotting of cortical protein extract.  An anti-GFP antibody detected a 
band at 130 kDa, which corresponds to VGluR1, in protein extract from 
transgenic, but not wild-type cortices (Figure 15C).   
 
Expression of Venus-GluR1 in cortical and hippocampal neurons 
We next sought to examine the expression pattern of VGluR1 in the mouse 
cortex using immunohistochemistry with a goat anti-GFP antibody.  Tissue 
from several founder lines was examined, but the fusion protein was not 
detectable by in the cerebral cortex.  However, one founder line (LH-
Otx1VGluR1-7) showed robust expression in the hippocampus, specifically 
in regions CA3 and dentate gyrus (Figure 16A).  Hippocampal expression 
was specific to this particular founder line, suggesting that it is due to the 
genomic position of the Otx1-VGluR1 BAC transgene.  The fusion protein 
was localized to dendrites (Figure 16A, far right), rather than the soma or 
axon, corresponding to the correct localization of AMPA receptors.  An 
additional transgenic line, Otx1-GFP, which expresses soluble GFP under 
the Otx1 BAC regulatory elements was examined in an identical way and 
showed robust expression in cortical layer V neurons, but not in 
hippocampus (Figure 16A, left and [146]).   
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Figure 16.  Expression of the Otx1-Venus-GluR1 transgene.   
(A) Immunohistochemistry of fixed brain tissue from Otx1-GFP and 
Otx1-VGluR1 mice using a goat anti-GFP antibody.  Robust GFP 
expression was detectable in brain sections from Otx1-GFP mice in layer 
V of the cerebral cortex.  Brain sections from Otx1-Venus-GluR1 
(Otx1VGluR1) showed expression of the VGluR1 fusion protein in 
hippocampus (CA3 and dentate gyrus).  VGluR1 expression was not 
detectable in the cerebral cortex.  A higher magnification image of 
staining in the hippocampus showed VGluR1 localized to dendrites, and 
excluded from soma and axons.  (B) A crude synaptosome preparation 
was carried out on cortical and hippocampal tissue from Otx1-VGluR1 
mice.  Fractions were subject to SDS-PAGE and immunoblotted with 
anti-GFP and other markers.  Synaptic proteins were detectable in the 
synaptic fraction, S2.  S2 was solubilized with 1.0% Triton X-100 to 
enrich for synaptic protein complexes (S3).  This fraction was subject to 
affinity purification using an anti-GFP antibody.  VGluR1 was detected in 
the immunopurified (IP) material from both cortex and hippocampus.  
However, no additional synaptic proteins were co-immunopurified with 
the VGluR1 fusion protein.  Scale bars: left and center panels = 200um, 
right panel = 50um. 
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Figure 16. Expression of the Otx1-Venus-GluR1 transgene. 
 
The additional hippocampal expression of the fusion protein in Otx1-
VGluR17 was potentially useful in that it might allow an in-subject 
comparison between excitatory synapses from two distinct tissues, the 
hippocampus and cerebral cortex, which could reveal site-specific GluR1 
interacting proteins. 
 Biochemical purification of a crude synaptic fraction was carried out 
as described [147] for both the hippocampus and cerebral cortex from the 
Otx1-VGluR1 mice.  An aliquot from each step of the purification was 
separated by SDS-PAGE and immunoblotted with anti-GFP (Figure 16B). 
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By immunoblotting, it was possible to detect VGluR1 only in the fractions 
collected from the hippocampal tissue.  Although immublotting of whole 
protein cortical extract showed the presence of VGluR1, it was undetectable 
after biochemical fractionation. 
Next, the crude synaptosome fraction was solubilized with 1.0% 
Triton X-100 in the case of cortex, and 0.1% Triton X-100 in the case of 
hippocampus, to enrich for synaptic protein complexes, including the PSD.  
This fraction, P3, was subject to co-immunopurification using a goat anti-
GFP antibody (Figure 16B).  The co-immunopurified material was separated 
by SDS-PAGE and immunoblotted with an anti-GFP antibody as well as 
additional antibodies for detection of synaptic and non-synaptic markers.  
While it was possible to detect the fusion protein in the IP from cortical 
PSDs, it was much less abundant than that found in hippocampal PSDs.  In 
addition, we did not co-immunopurify any additional AMPA receptor 
subunits, including the endogenous GluR1, nor GluR2.  PSD95 was also 
absent from the IP, as well as BIP and COX.  The failure to detect additional 
AMPA receptor subunits in this fraction can result from a failure of the 
fusion protein to correctly incorporate into functional AMPA receptors, from 
the failure of the receptor to traffic to the synapse, or from the method itself, 
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in which we are attempting to affinity purify from a very crude and complex 
sample of solubilized protein. 
 Because of the low expression of VGluR1 in cortex of Otx1-VGluR17 
transgenic mice, we focused our attention on the hippocampus, which 
robustly expressed VGluR1.  In order to better enrich the starting material 
for affinity purification we relied on gel filtration to separate large protein 
complexes from smaller, intracellular ones.  A percentage of each fraction 
was separated by SDS-PAGE and analyzed by immunoblotting (Figure 
17A).  Several markers of excitatory synapses were enriched in the early 
fractions, and are likely incorporated into large protein complexes.  These 
include Venus-GluR1 and the wild-type GluR1, as well as GluR2, PSD95 
and GRIP.  GABAARα1, a subunit of inhibitory neurotransmitter receptors, 
was concentrated in later fractions, indicating a separation of excitatory and 
inhibitory synaptic protein complexes under these conditions.  In addition, 
the endoplasmic reticulum (ER) marker, BIP, was largely excluded from the 
early fractions and enriched in the later fractions that contain smaller, 
trafficking protein complexes.  Wild-type hippocampal tissue was processed 
in the same way and immunoblotting of the fractions showed identical 
distribution of the proteins mentioned above, with the exclusion of 
VenusGluR1 (data not shown). 
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Figure 17. Gel filtration of a solubilized synaptic fraction from Otx1-
VGluR1 followed by affinity purification. (A) A crude synaptic fraction 
prepared from 10 hippocampi was solubilized with 0.1% Triton X-100 
and subject to gel filtration.  1.0% in volume of every fraction was 
separated by SDS-PAGE and assayed for the presence of excitatory 
synapse markers (PSD95, GluR1, GluR2), inhibitory synapse markers 
(GABAARα1), the endoplasmic reticulum marker, BIP and the 
mitochondrial marker, COX.  VGluR1 was detected using an anti-GFP 
antibody. (B) The early fractions (6-10) were pooled and affinity-purified 
using a mouse anti-GFP antibody (IP). 0.1% of the inputs and 25% of the 
affinity-purified samples (IP) were assayed by Western blot using an anti-
GFP antibody and showed immunoprecipitation of VGluR1 from the 
transgenic mouse.  The same blot was probed for wild-type GluR1, GluR2 
and PSD95, as well as the inhibitory neurotransmitter receptor subunit 
GABAARα1. 
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 Next, we pooled the fractions enriched for excitatory synaptic proteins 
and performed affinity purification with a mouse anti-GFP antibody (Figure 
17B).  The co-immunopurified material (IP) was separated by SDS-PAGE 
and immunoblotted with a rabbit anti-GFP antibody, which showed the 
presence of VGluR1 in the IP from Otx1-VGluR1 hippocampus.  The 
endogenous GluR1 subunit was also present in the IP, as well as an 
additional AMPA receptor subunit, GluR2, indicating that the VGluR1 
fusion protein can assemble with wild-type AMPA receptor subunits.  
Despite this, we did not detect any additional excitatory synaptic proteins, 
such as PSD95, indicating that the VGluR1 containing AMPA receptors 
may not incorporate properly into the synapse.  
 
Generation of transgenic mice expressing Venus-GluR1 in various cortical 
laminae. 
 Despite the failure of VGluR1 to successfully co-immunopurify 
synaptic proteins when expressed under Otx1 regulatory elements, we were 
not convinced that this fusion protein did not traffic to the synapse.  It was 
possible that the Otx1 driver was simply not sufficient for expression of this 
fusion protein in cortex, or that the fusion protein was regulated differently 
in the Otx1-positive layer V pyramidal neurons.  In order to test this 
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hypothesis, and to facilitate a comparative study of GluR1-containing 
excitatory synapses, we generated multiple lines of transgenic mice, each 
expressing VGluR1 in a distinct cortical pyramidal cell population (Figure 
18).   
 Each of the BAC drivers was selected for its specificity to pyramidal 
neurons in a distinct layer of mouse cerebral cortex (Figure 8 and [146]).  
The BAC modification was carried in a manner similar to Otx1-VGluR1, 
except that resolution of the intervening shuttle vector sequences was not 
necessary due to the improvement of the BAC modification technique.  Four 
BAC drivers, Drd4, Glt25d2, March4 and Ntsr1 were modified such that the 
Venus-GluR1 fusion protein was expressed instead of the endogenous 
protein (Figure 18A). 
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Figure 18.  Generation of multiple BAC transgenic lines expressing 
Venus-GluR1.  (A) Four BACs, Drd4, Glt25d2, March4 and Ntsr1, were 
selected based on their expression in distinct cortical pyramidal cell 
populations.  Each was modified such that the Venus-GluR1 cDNA was 
inserted at the level of the ATG.  The amount of upstream regulatory 
genomic sequences in each BAC is indicated.  Insertion of the transgene 
and shuttle vector (sv) sequences (not illustrated) introduced two 
additional EcoR1 sites into the BAC.  Scale bar = 20 kB. (B) Southern 
blotting was used to confirm correct co-integration of the shuttle vector-
transgene construct into the BAC.  The probe (red box in A) corresponded 
to those sequences used for homologous recombination and hybridizes to 
two distinct restriction bands in the co-integrate (c).  (C) Cortical protein 
extract was collected from wild-type and transgenic mice and 
immunoblotted for the presence of Venus-GluR1.  All four BAC 
transgenic lines express the transgene, although the level of expression is 
not more than that seen for Otx1-VGluR1.  Cortical synaptic protein from 
Glt25d2-VGluR1 was further analyzed by preparation of a solubilized 
crude synaptic fraction (S3) subject to immunopurification with a mouse 
anti-GFP antibody (C, right).  Venus-GluR1 was successfully 
immunopurified from the PSD fraction. 
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Figure 18. Generation of multiple BAC transgenic lines expressing 
VGluR1. 
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Correctly modified BACs were shown by Southern blotting to contain two 
additional bands, due to the presence of EcoR1 restriction sites introduced 
with the VGluR1-modified shuttle vector sequences (Figure 18B).  Each 
modified BAC was purified and injected into oocytes, which were surgically 
implanted into pseudopregnant females.  Successful incorporation of the 
transgene was confirmed by dot blotting and PCR genotyping of genomic 
DNA (data not shown).   
 To confirm expression of VGluR1 in the cortex of each BAC 
transgenic line, we collected cortical protein extract and immunoblotted with 
an anti-GFP antibody (Figure 18C, left panel).  The fusion protein was 
present in Glt25d2-VGluR1 cortical protein extract at a similar level to the 
previously analyzed line, Otx1-VGluR1.  Immunoblots of cortical extract 
from Ntsr1-VGluR1 and March4-VGluR1 also detected VGluR1, but at 
considerably lower levels.  Cortical extract from Drd4-VGluR1 did not 
contain any detectable VGluR1 protein (data not shown).  These results were 
consistent across several founder lines for each BAC.  Furthermore, 
immunoblotting detected the VGluR1 fusion protein in a solubilized, PSD-
enriched fraction (S3) from cortices of Glt25d2-VGluR1 mice (Figure 18C, 
right panel).  We were able to immunopurify VGluR1 from this fraction 
using a mouse anti-GFP antibody, as shown by immunoblotting the IP 
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material with a rabbit anti-GFP antibody.  We attempted to further analyze 
the expression of the transgene in these cortical expression lines by 
immunohistochemistry of fixed brain tissue.  However, as in the case of 
Otx1-VGluR1 (Figure 16A), the fusion protein was undetectable in cortex 
by immunohistochemistry for all of the lines (data not shown). 
 Because of the relatively high level of expression of VGluR1 under 
the Glt25d2 BAC regulatory elements, this line was subject to further 
biochemical analysis.  A crude synaptic fraction was prepared from five 
cortices and solubilized with 1.0% Triton X-100, followed by size exclusion 
chromatography on a Sephacryl S1000 column.  A percentage of each 
fraction collected was separated by SDS-PAGE and immunoblotted for 
various proteins (Figure 19A).  The early fractions, which contain large 
protein complexes, were enriched in excitatory synaptic proteins (GluR1, 
GluR2, PSD95, GRIP) and the mitochondrial marker, COX.  The smaller, 
likely intracellular protein complexes were enriched in later fractions and 
contained makers of inhibitory synapses (GABAAR α1, GABAARβ2/3) and 
the ER marker, BIP.  Because of the low level of expression of VGluR1, it 
was not possible to detect the fusion protein in the dilute fractions collected 
after gel filtration.  In order to confirm the presence of the fusion protein in 
the various fractions, and to assess its distribution, we performed 
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Figure 19.  Gel filtration of a solubilized synaptic fraction from 
Glt25d2-VGluR1 transgenic mice followed by affinity purification.  
(A) A crude synaptic fraction was prepared from 5 cortices, solubilized 
with 1.0% Triton X-100 and subject to gel filtration.  Each fraction was 
assayed for the presence of excitatory synapse markers (PSD95, GluR1, 
GluR2, GRIP), inhibitory synapse markers (GABA(A)Rα1, 
GABA(A)R β2/3), the endoplasmic reticulum marker, BIP and the 
mitochondrial marker, COX.  VGluR1 was immunopurified from each 
fraction using a mouse anti-GFP antibody and detected via 
immunoblotting with a rabbit anti-GFP antibody. (B) Fractions 6-10 were 
pooled and affinity-purified using a mouse anti-GFP antibody and showed 
immunoprecipitation of VGluR1 from the transgenic mouse (IP Tg) but 
not wild-type (IP Wt).  The same blot was probed for wild-type GluR1 
and PSD95, as well as the inhibitory neurotransmitter receptor subunit 
GABAARα1. 
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immunopurification of each fraction using a mouse anti-GFP antibody 
(Figure 19A, bottom).  The immunopurified material from each fraction was 
immunoblotted with an anti-GFP antibody, which detected VGluR1 in each 
fraction, however, the distribution of the fusion receptor differed from that 
of the endogenous GluR1 subunit.  While both the fusion and wild-type 
GluR1 subunits were enriched in the early fractions, which contain large 
protein complexes, Venus-GluR1 was also enriched in the later fractions, 
presumably in other intracellular compartments.  Tissue from wild-type 
cortex was processed simultaneously and showed identical distribution of 
wild-type proteins in the biochemical fractions as well as the absence of 
VGluR1 (data not shown). 
 Next, we pooled the early fractions (6-9) from both Glt25d2-VGluR1 
and wild-type cortices and performed affinity purification using a mouse 
anti-GFP antibody (Figure 19B).  VGluR1 was detected by immunoblotting 
in the IP from transgenic but not wild-type cortex.  The endogenous GluR1 
was only slightly enriched in the IP from Glt25d2-VGluR1, compared to 
wild-type.  PSD95, the major excitatory synaptic scaffolding protein, and the 
AMPA receptor subunit GluR2 (not shown) were absent from the IP, as was 
the inhibitory neurotransmitter receptor subunit GABAARα1.  As in the case 
of Otx1-VGluR1, it appears that VGluR1 expressed under control of 
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Glt25d2 regulatory elements does not traffic properly to excitatory synapses, 
and perhaps does not form functional receptors. 
 
Summary 
 Protein profiling in the mouse central nervous system necessitates that 
one compare multiple synapse types.  Using the BAC transgenic approach 
we generated multiple transgenic lines each expressing a Venus-GluR1 
fusion protein in a distinct pyramidal cell population.  We intended to purify 
GluR1-containing PSDs from each of these five pyramidal cell populations 
and analyze the components by mass spectrometry for a comparative study.  
Included in our study was Otx1-VGluR1, which would provide a useful 
comparison to Otx1-VGABAARα1, a transgenic line that contains affinity 
tagged inhibitory synapses. 
 The fusion protein showed correct topography in non-neuronal cells, 
was successfully integrated into each BAC and was expressed by multiple 
founder mice for each transgenic line generated.  Unfortunately, the 
expression levels of this fusion protein in cortex were relatively low, and not 
detectable by immunohistochemical methods.  Nevertheless, we were able to 
detect protein in cortical protein extract, demonstrating that the fusion 
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protein was expressed under the control of the various BAC regulatory 
sequences.   
 One Otx1-VGluR1 founder line expressed the fusion protein at robust 
levels in CA3 and dentate gyrus of hippocampus.  We further analyzed the 
hippocampus from this line and the cortex of an additional line, Glt25d2-
VGluR1, for biochemical enrichment of VGluR1 in large protein complexes 
that contain other markers of excitatory synapses.  VGluR1 was present in a 
crude synaptic fraction and in large protein complexes separated by gel 
filtration, but at extremely low levels and in a distribution that differed from 
wild-type GluR1.  In addition, affinity purification of these pooled fractions 
showed that VGluR1 did not co-immunopurify PSD95, an abundant 
constituent of the excitatory postsynaptic specialization.  Endogenous GluR1 
was only minimally enriched in the IP from these transgenic lines.  Together 
these results suggest that Venus-GluR1 does not successfully incorporate 
into synapses when expressed at physiological levels in both hippocampus 
and cortex of adult mice. 
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CHAPTER V. PROTEIN PROFILE OF INHIBITORY SYNAPSES IN 
CEREBRAL CORTEX 
Introduction 
 Synaptic activity in the central nervous system is defined as being 
either excitatory or inhibitory, depending on the resulting change in 
postsynaptic membrane potential.  The two types of input are 
morphologically, biochemically and functionally distinct.  Fast synaptic 
inhibition in the brain and spinal cord is mediated largely by ionotropic 
GABA receptors, which are pentameric chloride ion channels [24].  GABAA 
receptors also represent a major site of action of clinically relevant drugs, 
such as benzodiazepines, barbiturates, ethanol, and general anesthetics.  The 
precise subunit composition of a given GABAA receptor determines its 
expression pattern, subcellular localization and ligand affinities [2, 166-168].   
The most common composition consists of two alpha, two beta and one 
gamma subunit, with the α1 subunit expressed most abundantly in the 
central nervous system [2, 3].   
Excitatory synapses are easily enriched and purified biochemically 
due to the presence of a detergent insoluble post-synaptic density (PSD), 
thus the molecular architecture of these synapses is described in great detail 
in the literature [25, 68, 169].  Inhibitory synapses, on the other hand, lack a 
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large PSD and have not been purified or defined biochemically.  Several 
known protein constituents of inhibitory synapses were described in the 
introduction.  A key component, gephyrin, is thought to be the major 
scaffolding protein of this synapse.  However, it has not been shown to bind 
directly to GABA receptors, and is not necessary for clustering of all GABA 
receptor subunits [28].  Because many of the proteins thought to colocalize 
at inhibitory synapses are gephyrin-binding proteins, the list of inhibitory 
synaptic elements is not conclusive.  Furthermore, many of these 
interactions have been shown exclusively in vitro [170]. 
 We have designed a novel in vivo method to biochemically purify and 
analyze synaptic protein complexes and have applied this to GABAARα1 
containing synapses in a specific class of layer V cortical pyramidal neurons.    
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Results 
Tagging inhibitory synapses in layer V cortical pyramidal neurons 
In order to specifically purify inhibitory synapses from layer V cortical 
neurons, we took advantage of the BAC transgenic approach for transgene 
expression.  We selected the Otx1 BAC, which drives expression in a 
specific population of layer V pyramidal neurons.  The Otx1 BAC was 
modified to express a fusion protein consisting of the GABAA receptor α1 
subunit N-terminally fused to an affinity tag, Venus (Figure 20A).  We first 
transfected Venus-GABAARα1 (VGABAARα1) cDNA into HEK293 cells.  
SDS-PAGE followed by immunoblotting with an anti-GFP antibody showed 
that the protein was expressed and migrated at the expected size of 75 kDa 
(data not shown).  In addition, immunocytochemistry of non-permeabilized 
HEK293 cells showed that the fusion protein was inserted into the plasma 
membrane with the correct topographical organization, that is, with the 
affinity tag, Venus, localized extracellularly (data not shown).   
 We then went on to modify the Otx1 BAC such that the Otx1 ATG 
was disrupted by insertion of the Venus-GABAARα1 cDNA (Figure 20D).  
Successful modification of the BAC was checked by Southern blot (Figure 
20B).  The insertion of the cDNA introduces an additional EcoR1 restriction  
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Figure 20.  Tagging inhibitory synapses in a population of cortical 
layer V pyramidal neurons. (A) The GABAA receptor α1 subunit was 
N-terminally fused to an affinity tag, Venus.  The topography of the 
receptor positions Venus extracellularly, to allow for efficient purification 
of the synaptic complex.  (B) Correct modification of the Otx1 BAC with 
the Venus-GABAARα1 fusion construct was confirmed with Southern 
blot (EcoRI digest, probe shown as red bar in (D)), before injection into 
mouse oocytes. (C) Immunoblot analysis of cortical extract from both 
wild-type (Wt) and transgenic (Tg) mice, using an anti-GFP antibody, 
confirmed expression of Venus-GABAARα1.  The fusion protein migrates 
at the expected size of 75 kDa and is present only in extract from the 
transgenic mouse.  A nonspecific band is present in both extracts at  
50 kDa. (D) Schematic diagram of the modification of the Otx1 BAC with 
the Venus-GABAARα1 construct.  Otx1 is expressed specifically in a 
subpopulation of cortical layer V pyramidal neurons.  Otx1 expression 
was disrupted by introduction of the fusion construct at the level of the 
Otx1 atg.  The red bar indicates the probe used in (A).  The arrow denotes 
the likely start of regulatory sequences, based on the presence of upstream 
coding region for an unrelated gene.  Scale bar = 2 kB.  
(E)  Immunohistochemistry using an anti-GFP antibody confirmed the 
expression of Venus-GABAARα1 in cortical layer V pyramidal neurons.  
Brain sections from wild-type mice showed no detectable expression of 
GFP, while the Otx1-Venus-GABAARα1 transgenic mice showed robust, 
and specific layer V cortical expression.   A magnified view shows the 
expression of the fusion protein in pyramidal cell soma (arrows) and 
dendrites (arrowheads), in accordance with the known location of 
inhibitory synaptic input. 
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Figure 20. Tagging inhibitory synapses in a population of cortical layer 
V pyramidal neurons. 
 
site into the BAC, causing the modified BAC to hybridize the probe on a 
restriction fragment of smaller size. 
The correctly modified Otx1-Venus-GABAARα1 BAC was then 
injected into oocytes, which were surgically implanted into pseudopregnant 
females.  Genomic DNA was purified from founder mice and analyzed by 
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PCR (data not shown) and Southern blotting for successful insertion of the 
transgene (Figure 20B, right).  Southern blotting of genomic DNA from the 
transgenic mouse shows hybridization at restriction bands of two sizes, the 
larger band corresponds to wild-type Otx1, while the smaller band 
corresponds to the Otx1-Venus-GABAARα1 transgene. 
 Expression of the transgene in vivo was confirmed by collecting 
cortical protein extract.  Proteins were separated by SDS-PAGE and 
immunoblotted with a rabbit anti-GFP antibody (Figure 20C).  Extract from 
transgenic mice contained a band corresponding to the VGABAARα1 fusion 
protein, while wild-type extract lacked the fusion protein.  A nonspecific 
band (50 kDa) was present at equivalent levels in both extracts.  Otx1-
VGABAARα1 transgenic mice were further analyzed by 
immunohistochemistry of fixed brain sections using a rabbit anti-GFP 
antibody (Figure 20E).  VGABAARα1 was detected specifically in layer V 
pyramidal neurons in the brain sections from transgenic mice, while no 
signal was detected in wild-type brain sections (Figure 20E, far left).  The 
fusion protein was detected in the cell body as well as the proximal and 
distal dendrites, which corresponds to the known localization of inhibitory 
synaptic inputs (Figure 20E, right).  
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 To further demonstrate the correct subcellular localization of 
VGABAARα1, we performed immuno-electron microscopy on fixed brain 
sections (Figure 21).  We detected VGABAARα1 at the synaptic membrane 
apposed to inhibitory terminals, which were visualized by immunostaining 
with an anti-GAD65/67 antibody.  These synapses were found on the cell 
body of layer V pyramidal neurons (Figure 21A, C) and dendrites (Figure 
21B, D).  The inhibitory terminals were identified by the presence of GAD, 
the shape and size of the synaptic vesicles, and the lack of PSD (symmetric 
synapse).  VGABAARα1 was not present at excitatory terminals except in 
cases where a single spine head was innervated by both excitatory and 
inhibitory terminals (Figure 21D).  VGABAARα1 was also found 
prominently in subcellular compartments (Figure 21A, inset), most likely as 
part of trafficking complexes. 
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Figure 21.  Immuno-electron microscopy confirms Venus-
GABAARα1 localizes to inhibitory synapses.  VGABAARα1 
immunolabeling is revealed by the SIG procedure in figures (A), (B), and 
(D) and by the DAB procedure in figure (C).  Inhibitory terminals are 
immunoreactive for GAD65/67, which is revealed with the DAB 
procedure.  (A) A GAD immunoreactive terminal, indicated by an 
asterisk, contacts the soma of a layer V pyramidal neuron and colocalizes 
with Venus-GABAARα1, indicated by an arrow.  VGABAARα1 
immunoreactivity is also seen intracellularly (arrowhead and inset).  
Asymmetric synapses are immunonegative for both GAD and 
VGABAARα1 (dashed arrows).  (B) A GAD immunoreactive terminal 
(asterisk) colocalizes with Venus-GABAARα1 (arrow) on the dendritic 
shaft.  (C) A layer V pyramidal cell expresses VGABAARα1 
intracellularly (arrowhead) and on the plasma membrane.  The expression 
colocalizes with a GAD immunoreactive terminal (asterisk).  (D) A GAD 
immunoreactive terminal (asterisk) makes a symmetric synapse onto a 
spine head that is immunopositive for VGABAARα1 (arrow).  The same 
spine also forms an asymmetric synapse (dashed arrow) that is 
immunonegative for GAD.  An additional spine (upper left corner, dashed 
arrow) makes only an asymmetric synapse and is immunonegative for 
VGABAARα1.   Scale bars: A-C = 500µm; D = 100 µm.  Cy: cytoplasm. 
Nu : nucleus.  Sh: spine head.  De: dendrite. 
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 Figure 21. Immuno-electron microscopy confirms Venus-GABAARα1 
localizes to inhibitory synapses. 
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Biochemical purification of inhibitory synaptic protein complexes 
After confirming the correct subcellular localization of the Venus-
GABAARα1 fusion protein we went on to biochemically purify the tagged 
synapses.  Several methods for purification of GABA receptors have relied 
on detergent solubilization of a synaptic fraction, most frequently using the 
detergent sodium deoxycholate [171].  While these methods are useful for 
purifying intact receptors, we were not able to purify synaptic protein 
complexes in this way (data not shown).  Instead, we made several 
modifications to the novel method we devised to purify tagged parallel fiber-
Purkinje cell synapses of the cerebellum (Figure12A).  Optimization of this 
method for enrichment of VGABAARα1 tagged synapses proved successful.   
Cortices from five mice were homogenized and a crude synaptosome 
fraction was obtained by differential centrifugation.  Solubilization of this 
fraction in a final concentration of 0.1% Triton X-100 proved sufficient to 
purify intact inhibitory synaptic complexes.  Sodium deoxycholate and 
CHAPS were also tested for their ability to solubilize Venus-GABAARα1.  
Sodium deoxycholate was efficient in solubilizing the GABA receptor but it 
disrupted receptor-protein interactions, while CHAPS was inefficient (data 
not shown).   
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After solubilization, the S3 fraction was separated by size-exclusion 
chromatography using the gel filtration resin, Sephacryl S1000.  In this way, 
it was possible to separate large protein complexes containing VGABAARα1 
from those that were smaller, and likely corresponding to intracellular 
protein complexes.  Protein from each fraction was separated by SDS-PAGE 
and subject to immunoblotting for known markers of inhibitory and 
excitatory synapses, as well as the endoplasmic reticulum (ER) marker, BIP, 
and the mitochondrial marker, COX (Figure 22A).  The early fractions (6-
10) were enriched for synaptic and mitochondrial proteins, while the ER 
marker was selectively enriched in the later fractions (11-14), further 
validating their distinct subcellular localization.  VGABAARα1 was detected 
using a rabbit anti-GFP antibody and segregated in the gel filtration fractions 
similarly to wild-type GABAARα1.  The GABA receptor subunits α1, β2/3 
and γ2, as well as the scaffolding protein, gephyrin, were distributed 
throughout the fractions, suggesting their incorporation in protein complexes 
of both large and small size.  GABAARα2, on the other hand, showed 
selective enrichment in the earlier fractions, more closely resembling the 
excitatory synaptic components, such as PSD95 and GluR2.  The difference 
in fractionation of the GABAARα1 and -α2 subunits correlates to known 
differences in their immunocytochemical localization and clustering [97].   
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Figure 22.  Enrichment of inhibitory synaptic fractions followed by 
affinity purification of VGABAARa1 tagged synapses. (A) We 
prepared a crude synaptosome fraction, P2, which was solubilized in 0.1% 
Triton X-100 and centrifuged to prepare a fraction, S3, enriched in 
inhibitory synaptic complexes. The extract was then separated on a 
Sephacryl S1000 gel filtration column. 0.1% in volume of every fraction 
was analyzed by immunoblotting for the presence of inhibitory synapse 
markers (GABA(A)Rα1, GABA(A)Rα2, GABA(A)Rβ2/3, 
GABA(A)R γ2, gephyrin), excitatory synapse markers (PSD95, GluR2), 
the endoplasmic reticulum marker, BIP and the mitochondrial marker, 
COX. VGABAARa1 was detected using an anti-GFP antibody. The red 
rectangle outlines the “synaptic” fractions enriched for synaptic markers 
and pooled for subsequent affinity-purification of VGABAARa1 tagged 
synapses.  Protein dosage was performed on every fraction collected. The 
void volume was determined by the elution of Dextran blue sulfate.   
(B) Synaptic fractions (Input 6-10) from Otx1-VGABAARa1 mice were 
pooled and affinity-purified using a mouse anti-GFP antibody (IP 
VGABAARa1).  In parallel, control purifications were performed on 
preparations from Otx1-GFP transgenic mice (IP GFP). 1.0% of the 
inputs and 10% of the affinity-purified samples (IP) were assayed by 
Western blot using an anti-GFP antibody and showed 
immunoprecipitation of both VGluRδ2 and GFP, respectively.  The same 
blot was probed for different synaptic markers and the mitochondrial 
protein COX, showing specific co-immunopurification of inhibitory 
synaptic markers. 
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Figure 22. Enrichment of inhibitory synaptic fractions followed by 
affinity purification of VGABAARa1 tagged synapses. 
 
The same purification scheme was used to enrich for inhibitory synaptic 
proteins from an Otx1-GFP transgenic mouse, which expresses soluble GFP 
in the equivalent population of pyramidal neurons, and serves as a control 
for affinity purification.  The distribution of proteins was identical in 
fractions purified from the Otx1-GFP cortices (not shown). 
Next, synaptic fractions 6-10 from Otx1-GFP or Otx1-VGABAARα1 
were pooled and subject to affinity purification using a mouse monoclonal 
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anti-GFP antibody.  The affinity-purified proteins were separated by SDS-
PAGE and immunoblotted for both synaptic and nonsynaptic proteins 
(Figure 22B).  We detected either GFP or VGABAARα1 in the 
immunopurified (IP) material using an anti-GFP antibody.  The wild-type 
GABAA receptors α1, β2/3 and γ2 were detected in the IP from the Otx1-
VGABAARα1 mouse, confirming that the fusion protein incorporates 
correctly with the endogenous GABAAR subunits.  Alternatively, GABAA 
receptor α2 was absent from the IP lane.  Excitatory synaptic components, 
such as PSD95, GluR1 and GluR2 were also absent from the IP, as well as 
the ER marker, BIP, and the mitochondrial marker, COX.  Material from the 
Otx1-GFP control mouse lacked any co-immunopurified proteins, 
confirming the specificity of our affinity purification technique.  Standard 
amounts of soluble GFP were also run on the gel, to allow approximation of 
the quantity of fusion protein.  This was useful in determining the amount of 
protein to pool for analysis by mass spectrometry.   
 
Mass spectrometry of cortical inhibitory synapses 
 Affinity purified synaptic material was pooled from 25 cortices from 
either Otx1-Venus-GABAARα1 or Otx1-GFP and analyzed by mass 
spectrometry.  Proteins were alkylated and denatured, separated by SDS-
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PAGE and stained with zinc.  Excised bands were digested with trypsin and 
the resulting peptides subject to liquid chromatography-tandem mass 
spectrometry (LC-MS/MS).  Using this method we have so far generated a 
list of 12 proteins found specifically in the material immunopurified via 
VGABAARα1, and absent from the material purified via GFP (Table 5). 
 Mass spectrometry identified several wild-type GABAAR subunits, 
including α1, α2, α3, β1, β2, β3 and γ2, all of which are expressed in 
inhibitory cortical pyramidal cells.  It is noteworthy that GABAARα2 
subunit was present, as this subunit was not detectable by immunoblotting of 
the same material.  This is likely due to the difference in abundance of the 
immunopurified material in the two types of analysis.  Absent from our co-
IP were several non-cortical GABAAR subunits, including α6, which is 
exclusively expressed in cerebellar granule cells and the cochlea, and the γ1 
subunit, which is enriched in the amygdala, pallidal areas, the substantia 
nigra and the inferior olive [3].   
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sequence unique
Protein name (a) ensemble #    (b) MW(kDa) log(e)+ (c) coverage(%) (d) peptide # (e) peptide # (f)
Isolated GABA(A) receptor subunit alpha-1 00000020707 51.7 -107.6 29.4 17 8
proteins GABA(A) receptor subunit alpha-2 000000572 51.1 -61.9 19.5 8 3
(mus GABA(A) receptor subunit alpha-3 00000062638 55.4 -36.3 9.5 5 2
musculus) GABA(A) receptor subunit beta-2 00000007797 54.6 -74.1 27.4 10 4
GABA(A) receptor subunit beta-1 00000031122 54.1 -46.9 19.2 7 2
GABA(A) receptor subunit beta-3 00000038051 54.1 -46.7 22.2 9 2
GABA(A) receptor subunit gamma-2 00000063812 55.1 -13.9 7.8 3
Synaptic vesicle glycoprotein 2B 00000065495 77.4 -6.2 3.2 2
Gephyrin 00000054064 80.7 -20.4 6.1 4
Neuroligin-2 00000053097 90.9 -143.3 21 16
Glutamate receptor ionotropic, AMPA 2 00000074787 98.7 -18.9 5 5
Homer protein homolog 1 (VASP/Ena-related gene) 00000079026 41.6 -19.9 10 4
Likely Alpha-actinin-1 00000021554 103 -44.5 8 6
contaminants Alpha-actinin-2 00000067708 103.8 -7.8 2.6 2
Table 5.  Proteins uniquely immunopurified via Venus-GABAARα1 
were determined by subtracting proteins immunoisolated via GFP.  
(a) Proteins were identified by the GPM protein sequence database search 
program using data from LC-MS/MS experiments.  (b) Ensemble # is the 
protein accession number in Ensemble Mouse database.  (c) Log(e) is the 
base-10 log of the expectation that an assignment is stochastic.   
(d) Sequence coverage shows the percentage of protein sequence covered 
by the identified peptides.  (e) Peptide # shows the number of identified 
peptides.  (f) Unique peptide # shows the number of peptide matches that 
are unique to the homologue, when more than one homologues are 
reported. 
 
Table 5. Proteins uniquely immunopurified via Venus-GABAARα1  
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Figure 23.  Immunoblot analysis confirms the presence of gephyrin 
and neuroligin-2 in immunopurified material.  Inhibitory synaptic 
complexes were biochemically enriched from 5 cortices and affinity 
purified using a monoclonal mouse anti-GFP antibody against soluble 
GFP (IP GFP) or Venus-GABAARα1 (IP VG(A)Rα1).  The total amount 
of IP was separated by SDS-PAGE and analyzed by immunoblotting for 
gephyrin and neuroligin-2 (NL-2). 
In addition to GABAA receptor subunits, we found two additional inhibitory 
synaptic proteins in the immunopurified material, gephyrin and neuroligin-2 
(NL-2).  Gephyrin, a microtubule binding protein, is a known component of 
inhibitory synapses [108, 172] and may be important for clustering of these 
receptors [107].  Neuroligin-2 is a cell adhesion molecule with known 
specificity for inhibitory synapses [138], which likely plays a role in 
synaptogenesis and maintenance of these contacts.  The presence of 
gephyrin and NL-2 in the IP was confirmed by immunoblotting (Figure 23). 
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Excitatory synaptic components are almost entirely excluded from the IP, 
with the exception of the AMPA receptor subunit, GluR2.  The presence of 
GluR2 was surprising given the absence of GluR2 on immunoblots, but 
might be relevant as it appeared in the absence of additional excitatory 
proteins, including additional AMPA receptor subunits and PSD95.   
 Two potentially novel members of inhibitory synapses were identified 
by mass spectrometry, Homer protein homolog 1 (Homer1) and Synaptic 
vesicle glycoprotein 2B (SV2B).  Homer is known to cluster components of 
the excitatory postsynaptic density [75], and may play a similar role at 
inhibitory synapses.  SV2B is located presynaptically and, together with 
SNAP-25 and synaptotagmin, functions in neurotransmitter release [173].  
Further work will be necessary to clarify whether SV2B is a contaminant or 
is localized postsynaptically at cortical inhibitory synapses. 
 
Summary. 
 We have successfully generated transgenic mice that express a Venus-
GABAARα1 fusion protein in layer V cortical pyramidal neurons.  Light and 
electron microscopy confirmed the presence of the tagged receptor at 
inhibitory synapses in the targeted cell type. A novel approach to the 
biochemical enrichment of inhibitory synaptic protein complexes followed 
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by affinity purification via the tagged receptor, proved efficient in isolating 
the inhibitory synaptic protein complex.  Mass spectrometry of this complex 
revealed twelve proteins, including several GABAAR subunits expressed in 
cortical pyramidal neurons.  We also identified two specific inhibitory 
synaptic clustering proteins, gephyrin and neuroligin-2, thus demonstrating 
the efficacy of our method for the in vivo biochemical purification of 
inhibitory synaptic complexes.    
Mass spectrometry also identified several components whose 
functions are not readily apparent.  The presence of excitatory AMPA 
receptor GluR2 subunit as well as Homer protein homolog 1, coupled with 
the absence of additional AMPA receptor subunits or the major excitatory 
scaffolding protein, PSD95, suggests a novel function or localization of 
these synaptic proteins.  Further analysis of this complex, including 
additional affinity purification experiments, will be required to determine the 
specificity of these proteins to inhibitory synapses in mouse cerebral cortex. 
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DISCUSSION 
Activity at the synapse, a discrete site of contact between the pre- and post-
synaptic neurons, is the basis for neurotransmission in the central nervous 
system.  Synapses are complex and dynamic structures, composed of a 
multitude of proteins, such as neurotransmitter receptors, scaffolding 
proteins, and signaling molecules.  Given that an individual neuron receives 
thousands of synaptic inputs, there likely exists a molecular mechanism for 
defining and maintaining unique synapse types.  To determine the protein 
specification for individual synapses it is necessary to purify and analyze the 
protein content of only a single class of synapse.  A comparative analysis of 
multiple synapse types could lead to valuable insights into the molecular 
mechanisms of synapse specification.  Such a comprehensive approach is 
possible due to the availability of hundreds of BAC vectors for neuronal 
cell-type specific expression of a transgene (www.gensat.org).  We have 
taken advantage of this approach to target individual cell types for 
expression of a synaptic affinity tag, which was then used to purify synaptic 
protein complexes.  Mass spectrometric analysis was used to generate a 
protein profile of each purified synapse type and to identify novel and 
functionally relevant synaptic proteins.   
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 We first targeted the parallel fiber to Purkinje cell (PF/PC) excitatory 
synapse of the cerebellum for purification and mass spectrometry analysis.  
The PF/PC synapse is unique in that it contains the orphan receptor, GluRδ2, 
which is genetically defined as being between NMDA and non-NMDA 
receptor types.  Although the precise function of GluRδ2 is not completely 
understood, is required for correct motor development and function, and has 
also been implicated in several neurological diseases [162].  It is also 
necessary for long-term depression in the cerebellum, and motor learning 
dependant on this structure [80].  A second excitatory input to the Purkinje 
cell is from climbing fibers (CF/PC), but these synapses do not contain 
GluRδ2 [65].  Proteomic analysis is likely to provide insight into the unique 
molecular and functional properties of the PF/PC synapse. 
 To analyze only the PF/PC synapse, we targeted expression of a 
Venus-GluRδ2 fusion protein to Purkinje cells of the cerebellum.  This 
fusion protein enabled affinity purification of the PF/PC synaptic protein 
complex using an anti-GFP antibody to recognize Venus.  A major 
advantage of employing a synaptic affinity tag is that it allowed comparison 
of the immunopurified proteins to those contaminants immunopurified via 
soluble GFP expressed in the same cell type.  In order to maximize recovery 
of synaptic proteins for analysis by mass spectrometry, we employed a novel 
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method of PSD purification that relied on gel filtration of a solubilized crude 
synaptic fraction.  Gel filtration resulted in a a pool of large protein 
complexes, enriched in excitatory synaptic proteins, including Venus-
GluRδ2, relative to trafficking and inhibitory synaptic proteins.  Affinity 
purification with an anti-GFP antibody was successful in purifying a large 
protein complex that contained GluRδ2 and other markers of excitatory 
synapses, such as GluR2 and PSD95, while components of inhibitory 
synapses and ER were absent. 
 Mass spectrometric analysis of this complex identified 65 proteins, 
which were organized into 11 functional categories.  Most of these 
categories have previously been included in descriptions of the postsynaptic 
specialization [174], but one category, “phospholipid metabolism and 
signaling” contained several members newly associated with the PF/PC 
synapse.  This group included eight proteins that can regulate or be regulated 
by phospholipid metabolism (Iptr1, synaptojanin 1 and 2, phospholipase B, 
ABCA12, MRCKγ) or contain phospholipid binding domains (Plekha7, 
annexin A6, MRCKγ).  This suggests that phospholipid regulation is a major 
feature of the PF/PC synapse, in accordance with the major role of the 
metabotropic glutamate receptor 1 (mGluR1) in regulating the physiology of 
the PF/PC synapse [67].  mGluR1 exerts its action by inducing 
  139 
phosphatidylinositol-4,5-P2 (PIP2) hydrolysis [175, 176].  Two of the 
proteins we identified, MRCKγ and Itpr1, respond to the metabolites of 
PIP2 hydrolysis (DAG and IP3, respectively) and may be key components of 
the molecular pathway by which mGluR1 functions at this synapse. 
 Phosholipid metabolism has been strongly implicated in presynaptic 
functions, such as vesicle recycling [177], and our results show that it also 
likely plays a role in postsynaptic regulation of the synapse.  In particular, 
two proteins we identified at PF/PC synapses, synaptojanin-1 and -2, are 
PIP2-metabolizing enzymes that are found both pre- and post-synaptically 
[174].  Another interesting member of this category, MRCKγ, has not 
previously been shown at PF/PC synapses and is known to modulate actin 
cytoskeleton and cell morphology [178].  This is interesting since 
deficiencies in spine length and spine morphology of Purkinje cells may play 
a role in neurodevelopmental diseases such as mental retardation and 
Angelman syndrome [145, 159]. 
The diversity of proteins present at the PF/PC synapse demonstrates 
the complexity of the PSD and suggests the possibility of a “synaptic code” 
to define individual synapse types.  Proteins that contain classical adhesion 
domains are commonly found at synapses and targeting of particular 
adhesion molecules could specify synapse types.  For example, our study 
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identified Neph1 and the receptor tyrosine phophatase, RPTPmu.  Given the 
known role of the C. elegans Neph1 homolog, SYG1, in specifying synapses 
in vivo, it is possible that Neph1 may play a role in specifying the PF/PC 
synapse as distinct from the CF/PC synapse.  Receptor tyrosine phosphatases 
play important roles in axon guidance, and have also been shown to control 
synapse formation [179].    
The majority of proteins identified in this study are specifically 
expressed in Purkinje cells.  This conforms with previous studies of 
expression analysis of proteins identified in bulk synapse preparations, 
which show that receptors and other upstream signaling molecules have a 
highly variable expression pattern in the vertebrate brain [180].  
Furthermore, the diversity of excitatory inputs within the Purkinje cells may 
suggest that quite distinct sets of proteins are necessary for specifying an 
individual class of synapse. 
 Our initial approach to the study of such specificity employed the 
expression of Venus-GluRδ2 fusion protein in the Purkinje cell, which is 
localized specifically to the PF/PC synapse.  In order to identify synaptic 
proteins enriched at other excitatory inputs to Purkinje cells, we sought to 
express a Venus-GluR2 fusion protein under the same BAC regulatory 
control elements.  Since GluR2 is present at both PF/PC and CF/PC 
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synapses [65], a subtraction method could be used to define a class of 
proteins differentially expressed at each synapse type.  Although it was 
possible to express Venus-GluR2 in HEK293T cells (not shown) this fusion 
protein was not expressed in vivo in the cerebellum (Pcp2-VGluR2) or in the 
cortex (Otx1-VGluR2). 
An instructive comparison to identify regulators of synaptic 
specificity is between excitatory synapses in distinct brain regions and/or 
cell types.  We took advantage of the available BAC vectors for cortical 
pyramidal cell expression to localize a Venus-GluR1 fusion protein to 
excitatory synapses in distinct cortical cell types.  Although VGluR1 was 
expressed with correct topography in HEK293 cells, only low levels were 
detectable in the cortex in vivo under control of several BAC vector 
sequences (Otx1, March4, Ntsr1, Drd4, Glt25d2).  One transgenic line, 
Otx1-VGluR17 expressed VGluR1 in CA3 and DG of hippocampus due to a 
positional effect of transgene insertion.  VGluR1 was highly expressed and 
appeared by immunofluorescence to localize to dendrites.  However, affinity 
purification of VGluR1 from hippocampus and cortex of Otx1-VGluR17, 
and from cortex of an additional line (Glt25d2-VGluR1) showed that this 
fusion protein did not likely traffic to synapses.   
Our findings that Venus-GluR2 and Venus-GluR1 are not correctly 
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localized to excitatory synapses in vivo are contrast with a number of studies 
that utilize these fusion proteins to examine AMPA receptor function [84, 
86-88, 181].  GFP-GluR1 fusion protein expressed in vitro mainly forms 
homomeric receptors that are distinguished electrophysiologically by 
alterations in their rectification properties [86, 87].  In one study, GPF 
tagged GluR2 was expressed in cultured hippocampal neurons, efficiently 
inserted into the synapse and was shown to interact with GRIP and NSF, 
known regulators of AMPA receptor trafficking [181].  In another study, 
GFP-GluR1 was introduced into neurons with the Sindbis virus expression 
system to levels three times that of endogenous GluR1 and trafficked 
efficiently to synapses [86].  In both experiments, recombinant GluR1 
subunits were distributed similarly to the endogenous GluR1 subunit and 
delivered to the synapse.   
There are several potential explanations for the differences in 
expression of tagged glutamate receptors in our BAC transgenic animals 
compared to those published in the literature.  First, there are likely greater 
regulatory constraints on glutamate receptor expression and trafficking in the 
intact brain than in dissociated neurons or organotypic slice cultures.  These 
differences may manifest by cell type, as exemplified by the higher level of 
expression of VGluR1 in hippocampus than in cortex, and the fact that most 
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studies of these recombinant receptors were carried out in dissociated 
hippocampal neurons or hippocampal slice cultures.  Tissue specific 
regulation of AMPA receptor trafficking is supported by the expression of 
distinct transmembrane AMPA receptor regulatory protein (TARP) isoforms 
in hippocampus and cortex, which interact with AMPA receptors at the post-
synaptic density and are required for their surface expression [182].  Second, 
most expression systems result in levels of AMPA receptor fusion protein 
those are much higher than endogenous levels.  If only a small percentage of 
GFP-GluR1 is properly assembled into synaptic protein complexes, it would 
be possible to detect this protein at synapses only when expressed at 
extremely high levels.  Third, homomeric GFP-GluR1 receptors may not be 
efficiently trafficked to the synapse in vivo at physiological levels of 
expression.   
 Finally, the fact that Venus-GluR2 was not expressed at all in our 
transgenic mice points to differences in the regulation and trafficking of the 
various AMPA receptor subunits [183, 184].  AMPARs assembled as GluR2 
homomers or GluR2/GluR3 heteromers cycle in and out of the synaptic 
membrane in a constitutive manner, which does not require synaptic activity 
[185, 186].  This constitutive trafficking requires GluR2-specific interactions 
with NSF [187].  In contrast, AMPARs containing the GluR1 subunit 
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translocate into spines and are inserted into synapses in response to NMDA-
receptor activation during LTP [84].  The constitutive nature of GluR2 
trafficking may indicate differences in regulation of assembly and insertion 
of this subunit and preclude the expression of a Venus-tagged GluR2 subunit 
at physiological levels in vivo. 
 Because we could not co-immunopurify any excitatory synaptic 
proteins via Venus-GluR1 or Venus-GluR2, it was not possible to profile 
additional excitatory synapses.  Improvements in the design of affinity 
tagged AMPA receptor subunits may facilitate their proper insertion into 
synapses and enable future studies. 
 In addition to excitatory synapses, we undertook a study of inhibitory 
synaptic protein complexes.  Because inhibitory synapses lack a detergent 
insoluble PSD, they have not been biochemically purified with classical 
methods.  Our alternative method relied on size exclusion chromatography 
rather than density centrifugation to enrich for large protein complexes.  
This approach enabled the purification of a complex of inhibitory synaptic 
proteins.  Using the BAC transgenic approach, we expressed a Venus-
GABAAα1 subunit in a subpopulations of pyramidal neurons of mouse 
cerebral cortex and showed that this receptor was similar to the endogenous 
GABAAα1 subunit in the various purification steps.  Interestingly, gel 
  145 
filtration revealed differences in the subcellular distribution of GABAAα1 
and α2 subunits.  The α2 subunit was concentrated in the early fractions, 
which contained large protein complexes, and its distribution resembled 
markers of insoluble excitatory PSDs.  By contrast, the α1 subunit was 
distributed throughout the fractions, in both large and small protein 
complexes.  These observations correlate with published differences in 
GABAA receptor subunit distribution in neurons.  For example, hippocampal 
pyramidal neurons cluster receptors containing α2 subunits at synapses on 
the axon initial segment and dendrites, whereas receptors containing α1 
subunits are more uniformly expressed [10, 96].  In addition, a diffuse 
GABAA receptor subunit immunoreactivity can be seen throughout the brain 
in addition to clusters, suggesting the presence of a sizable pool of 
extrasynaptic receptors [95, 108], as shown by postembedding immuno-
electron microscopy [96].  We also saw a large population of extrasynaptic 
Venus-GABAAα1 subunit by electron microscopy, and saw both the tagged 
and wild-type α1 subunits distributed across both large- and small-protein-
complex fractions during gel filtration.  The distribution of GABAA receptor 
subunits may be indicative of differences in their subcellular localization or 
unique trafficking properties.  A better understanding of such differences 
could be gained by subunit-specific proteomic analysis of GABAA receptor 
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interacting proteins. 
 We used affinity purification to explore the proteins present at Venus-
GABAAα1 tagged inhibitory synapses.  By pooling the purified material 
from an equivalent of twenty-five cortices, we were able to identify twelve 
proteins specifically immunopurified with Venus-GABAAα1.  This list is 
preliminary, as we have not yet replicated the mass spectrometry analysis.  
Of these twelve proteins, most were additional GABAA receptor subunits, 
including α1, α2, α3, β1, β2, β3, and γ2, all of which are expressed in 
inhibitory cortical pyramidal cells.  This result indicates that the tagged α1 
receptor assembles properly into mature GABAA receptors.  The α2 subunit 
is likely present in this complex at lower levels than wild-type α1, β2, β3 
and γ2, as it was not initially identified by immunoblotting of a small 
percentage of the purified material.  As described above, the α1 and α2 
subunits are thought to segregate into distinct receptor pools in vivo.  
Perhaps they only colocalize in a fraction of synapses, and this interaction is 
detectable only by the very sensitive methods of mass spectrometry for 
detection of proteins in a complex sample. 
In addition to the various receptor subunits, mass spectrometry 
positively identified gephyrin, a multidomain protein that likely provides a 
scaffold for postsynaptic proteins and an anchor to the cytoskeleton [28].  A 
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recent study has identified a 10-amino-acid sequence within the major 
intracellular domain of the α2 subunit that regulates the accumulation of 
GABAA receptors at postsynaptic specializations, in a process dependent on 
gephyrin [107].  Studies of the retina have shown that GABAA receptors 
containing the α1 subunit were not colocalized with gephyrin, suggesting 
that gephyrin was associated only with certain receptor subtypes [188].  
However, recent results indicate that in brain gephyrin does in fact 
colocalize with GABAA receptor subunits α1, α2,  and α3, as well as the  γ2 
subunit [98].  Our results provide further evidence that gephyrin is indeed 
present at GABAAα1 containing synapses.  
The precise function and localization of gephyrin in clustering of 
GABAA receptors remains elusive, as many studies have provided 
contrasting results.  Whereas removal of gephyrin by gene targeting or 
mRNA expression interference strongly affects GABAA receptor clustering 
[189], some GABAA receptor clusters can still form in neurons lacking 
gephyrin [110].  Furthermore, the subsynaptic localization of gephyrin in 
GABAergic synapses depends on GABAA receptor clustering. That is, when 
GABAA receptor postsynaptic clusters are disrupted by targeted deletion of 
the gene encoding the γ2 subunit, gephyrin clusters disappear and the 
receptors disperse in the cell membrane [190, 191].  The distribution of 
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gephyrin in our gel filtration fractions to both large and small protein 
complexes may underlie its divergent functions.  Inconsistencies in the data 
on the role of gephyrin at inhibitory synapses suggest the presence of 
additional clustering and scaffolding molecules that regulate inhibitory 
synaptic structure.   
One potential regulatory protein is neuroligin-2, a cell adhesion 
molecule involved in synapse formation [122, 192, 193] and localized 
specifically to inhibitory synapses in vivo [138].  Studies have shown that 
neuroligins are capable of inducing both excitatory and inhibitory 
presynaptic contact formation, and that the precise synapse formed depends 
on interactions of the appropriate neuroligin with scaffolding molecules, 
such as neurexin1-β and PSD95 [194].  For example, enhanced expression 
of PSD-95 induces clustering of NL-2 and NL-3 and shifts endogenous NL-
2 from inhibitory to excitatory synapses [195].  These findings provided 
evidence that assembly of specific postsynaptic elements can regulate a 
balance between excitatory and inhibitory synapses.  Thus, abnormalities in 
the expression of and/or interactions between these molecules may result in 
aberrant synapse formation and a change in the ratio of excitatory to 
inhibitory inputs.  An upset in the balance of excitatory and inhibitory 
synapses is thought to underlie complex psychiatric disorders [196-198].  
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The identification by mass spectrometry of NL-2, and the absence of NL-1, 
demonstrates the specificity and efficacy of our approach to purifying 
inhibitory synaptic protein complexes.  
 In addition to specific markers of inhibitory synapses, mass 
spectrometry of Venus-GABAA α1 tagged protein complexes identified two 
proteins that are typically found at excitatory receptors, AMPA receptor 
subunit GluR2 and Homer protein homolog 1.  It is noteworthy that the 
GluR2 subunit alone was localized to our tagged inhibitory synapses, since it 
is typically found as part of heteromeric receptors that contain either GluR1 
or GluR3 [199].  The GluR2 subunit of AMPA receptors interacts with NSF 
and this interaction has been shown to cause differences in intracellular 
sorting and trafficking of GluR2 compared to the other AMPA receptor 
subunits [184].  GABARAP, a GABAA receptor binding protein, also binds 
NSF and is involved in trafficking of receptors to the synapse [170, 200].  
Further analysis will be required to determine if AMPA receptor GluR2 
subunits are in fact localized to inhibitory synapses, and if this is mediated 
by GABARAP via their common interaction with NSF. 
 Homer protein homolog 1 (Homer1) is a member of the Homer family 
of adaptor proteins, which are predominantly localized to the PSD in 
mammalian neurons.  Each Homer protein has several variants, which are 
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classified primarily into the long and short forms.  The long Homer forms, 
which include Homer1, are constitutively expressed and consist of two 
major domains: the amino-terminal target-binding domain, which includes 
an Enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) homology 1 
(EVH1) domain, and the carboxy-terminal self-assembly domain containing 
a coiled-coil structure and leucine-zipper motif [75].  The EVH1 domain is 
homologous to that of mENA/VASP, a microfilament binding protein 
known to be involved in the structural organization of inhibitory synapses 
[111, 201].  Perhaps Homer1 also plays a role in the structural integrity of 
these synapses via its interaction with additional adapter molecules, although 
immunohistochemical analysis of Homer1 localization in cortical pyramidal 
neurons is necessary to confirm its presence at inhibitory synapses.  
Evidence for the presence of postsynaptic scaffolding proteins common to 
both inhibitory and excitatory receptors is supported by the identification of 
an isoform of GRIP1 that colocalizes with GABA receptor in cultured 
hippocampal neurons [112].  It is possible that we have identified a unique 
isoform of Homer in inhibitory synaptic protein complexes. 
 Our ability to tag and purify individual synapse types was facilitated by 
the use of BAC transgenesis for expression of synaptic tags in a multitude of 
cell types.  We have shown here that it is indeed possible to analyze an 
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individual class of synapse and generate a list of specific and functionally 
interesting synaptic proteins.  The value of such an approach lies in the 
ability to compare multiple synapse types across various brain regions.  
Already we can observe a striking difference in the molecular complexity of 
excitatory and inhibitory synaptic protein complexes.  This difference is 
expected, as the simpler, symmetric structure of inhibitory synapses suggests 
that they contain vastly fewer molecules.  In the case of both excitatory and 
inhibitory synapses we have identified novel potential synaptic components 
whose functional relevance will be assayed in future experiments.   
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